WO1995033504A1 - Ic-processed microneedles - Google Patents
Ic-processed microneedles Download PDFInfo
- Publication number
- WO1995033504A1 WO1995033504A1 PCT/US1995/007916 US9507916W WO9533504A1 WO 1995033504 A1 WO1995033504 A1 WO 1995033504A1 US 9507916 W US9507916 W US 9507916W WO 9533504 A1 WO9533504 A1 WO 9533504A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- shaft
- substrate
- microstructure
- interface region
- microneedle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
- A61B17/205—Vaccinating by means of needles or other puncturing devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
Definitions
- the present invention relates generally to microneedles, and more particularly to microneedles fabricated by micromachining techniques.
- needles are used to extract samples of substances from living tissue in order to analyze the substances for diagnostic purposes, or to deliver a drug or a medicine.
- the majority of needles in use today are macroneedles, which have a relatively large diameter as compared to a blood cell and are on the order of millimeters (mm) .
- the large diameter of the macroneedle shaft has the disadvantage of possibly damaging biological tissue during penetration. Additionally, tissue penetration by the needle is often painful to the patient because of the relatively large needle diameter.
- microneedles having a diameter on the order of micrometers have many applications. For instance, they may be used as precise injection/extraction needles in cell biology, as injection/extraction heads in a drug delivery system or microchemical factory, and as injection/extraction heads in microsurgery. It is also advantageous to have a smaller size needle because the reduced size decreases discomfort and pain to the patient.
- Still another object of the present invention is to provide a microneedle which may be mass produced.
- Yet still another object of the present invention is to provide a microneedle which is strong enough to reliably penetrate biological tissue.
- a further object of the present invention is to provide a microneedle which may incorporate micropumps, microvalves and microdetectors.
- the present invention is directed to an IC- processed microneedle formed from a substrate which defines an interface region and an elongated portion extending away from the interface region.
- a shaft is formed from the elongated region by a shell, which defines an enclosed channel within the shaft. One end of the shaft is attached to the interface region.
- the shaft includes ports which permit fluid to flow through the microneedle.
- the method of the present invention includes a sequence of steps for forming an IC-processed microneedle. First, a substrate is provided for forming an interface region and an elongated portion extending away from the interface region. A patterned non-planar etchable structure is then formed on the frontside of the elongated portion of the substrate.
- An unetchable membrane layer is deposited atop the etchable structure, and etching holes are opened in the membrane layer.
- One of the etching holes is at an end of the membrane layer and a second etching hole is positioned at a second end of the membrane layer.
- the etchable structure is etched to a predetermined extent to form a cavity underneath the membrane layer, thereby producing a shaft formed from the membrane layer and the elongated portion of said substrate.
- Figure 1A is a perspective view of an embodiment of a silicon processed microneedle.
- Figure IB is a cross-sectional view of the microneedle as taken along line IB-IB of Figure 1A.
- Figure IC is a cross-sectional view of the microneedle as taken along line 1C-1C of Figure 1A.
- Figure 2A is a plan view of the microneedle prior to detachment from the substrate.
- Figure 2B is a cross-sectional view of the microneedle as taken along line 2B-2B of Figure 2A.
- FIGS 3A-1 to 3N-2 schematically illustrate a microneedle fabrication process according to the present invention.
- the left-hand figures are taken along line 3L-3L of Figure 1A, and the right-hand figures are taken along line 3R-3R.
- Figures 4A and 4B are views illustrating a icroheater and its positioning relative to the microchannel, respectively.
- Figures 5A-5E show the sequence of steps in fabricating the microneedle with on-chip CMOS (complementary metal-oxide semiconductor) as taken along line 5-5 of Figure lA.
- Figure 6 is a schematic diagram showing the microneedle penetrating tissue in a first application of the present invention.
- Figure 7 is a schematic diagram including a detailed portion showing the microneedle penetrating tissue in another application of microneedle use.
- FIGS 8A and 8B show alternative embodiments of the microneedle.
- the present invention will be described in terms of the preferred embodiment.
- the preferred embodiment is an apparatus and method for fabricating IC-processed microneedles. Referring in detail to th- drawings, wherein like reference numerals designate like parts in several figures, and initially to FIG. 1A, a microneedle 10 in accordance with the present invention is illustrated.
- Microneedle 10 includes an interface region 11 and a shaft 14 having a icroflow channel 78 therein along its length.
- a distal end 20 of shaft 14 can be inserted into tissue (not shown) so that liquids
- a shank fluid port 22 is located on shank or proximal end 12 of shaft 14 to deliver or receive fluids.
- the microneedle may include more than two ports, as desired.
- Microflow channel 78 runs along the length of fully- enclosed microneedle shaft 14.
- a series of thin polysilicon heating resistors 60 are located on interface region 11 along the floor of microflow channel 78. Interface region 11 is sufficiently thick to permit incorporation of on-chip electronics 24 for real-time fluid analysis. Heating resistors 60 may be used to form a thermally-driven, cascaded-bubble icropump or simple heater.
- the microneedle may also include detector resistors 62 which extend along the bottom of the icrochannel (see FIG. IB) and are coupled to electrodes 84 (FIG. 3L-2) on the tip 86 of the needle.
- Microflow channel 78 is formed by removing sacrificial layers from underneath a shell 26 during processing. In order to access the sacrificial layer, etch access holes 74 are opened and then filled after etching. The fabrication procedures will be discussed below in . relation to FIGS. 3A-1 through 3N-2.
- FIG. IB shows a cross-section of fully-enclosed microflow channel 78.
- the channel height is approximately 9 ⁇ m, and is indicated by dimension "G” , and the channel width "H” may be between 30 ⁇ m to 60 ⁇ m.
- the needle height "I” is about 70 ⁇ m, and the needle width "J” is approximately 80 ⁇ m at the tip region.
- FIG. IC illustrates the positioning of a polysilicon resistor 60 on interface region 11.
- Contact pads 36 are situated on both sides of the microflow channel 78 at shank end 12 and provide an outside connection to resistors 60, which function as microheaters.
- detector resistors 62 cannot be seen in FIG. IC because this cross-section is taken along line 1C-1C on the interface region.
- the detector resistors extend along the length of the channel but do not extend into the interface region any further than is necessary to couple them to electronics 24. The location of both resistors can be best seen in FIG. 3N- 2.
- FIG. 2A is a plan view of a microneedle 10 before it is separated from wafer or substrate 46 by breaking beams 44.
- Support beams 44 connect microneedle 10 to substrate 46 and facilitate testing and manipulation of the microneedle prior to its final use.
- Area 40 marks the area where microneedle 10 will be separated from substrate or thin-film 46.
- Interface region 11 may be used as an integrated-circuit (IC) interface region of approximately 2 to 3 millimeters (mm) 2 .
- the tip region 86 is formed at an angle ⁇ of approximately 45° to the plane of the needle shaft 14, to form a sharp triangular tip 87.
- the width of the interface region, indicated by dimension "X”, is approximately 1.5 mm, and the length of the shaft, indicated by dimension “Y”, is between 1 and 6 mm.
- interface region 11 widens out to a large surface area, suitable for incorporation of additional integrated electronic and/or fluidic devices.
- Cross-sectional dimensions of a completed microneedle 10 are shown in FIG. 2B after if has been detached from wafer 46.
- Wafer 46 has an initial thickness of between 500 and 550 ⁇ m, as indicated by "Z”.
- the wafer thickness of the microneedle is reduced during fabrication.
- Shaft 14 has a thickness of approximately 50 ⁇ m indicated by dimension "I”.
- microneedle 10 tapers from the tip end 86, where it is approximately 80 ⁇ m wide, to 140 ⁇ m, where it joins the shank in order to increase strength.
- the retained single-crystal silicon layer 46 provides a rigid spine which adds strength to the needle. Note that there is no single- crystal silicon at the tip region 86, so that the tip is sharper and smaller than the portion of the shaft including single-crystal silicon.
- microneedle The fabrication sequence for formation of a microneedle is shown in FIGS. 3A-1 to 3N-2. Seven masks may be used.
- the drawings are not to scale, and dimensions should be taken from the text; the drawings are to illustrate the process, and not necessarily the preferred dimensions of the microneedle.
- the microneedle is formed using IC (integrated circuit) processing methods, e.g. oxidation, lithography, chemical vapor deposition, doping, and etching.
- IC integrated circuit
- microchannel 78 is surface-micro achined onto a single-crystal silicon substrate or thin-film 46 that is mostly etched from the wafer backside along shaft 14 in the final fabrication step.
- FIGS. 3A-1 AND 3A-2 show a ⁇ 100>-oriented lightly doped n-type silicon wafer 46 which is 500-550 ⁇ m thick.
- a thick masking layer 47 of silicon dioxide (Si0 2 ) 1.2 ⁇ m thick is thermally grown on wafer frontside 48 and backside 50.
- Masking layer 47 is patterned as shown, and boron is diffused at approximately 1125 °C for fifteen hours to form a 12 ⁇ m-deep heavily doped p-type region 52. Both the future interface region 11 and shaft 14 are indicated generally in these figures.
- Boron-doped region 52 defines tip region 84 (FIG. 2A) , extends along the needle shaft and defines the perimeter of interface region 11, as best shown in FIG. 2A. Boron-doped region 52 acts as an etchant stop since EDP (ethyleneidamine pyrocatacol and water) , used during fabrication, does not etch boron-doped silicon. Note that the boron-doped region is omitted from the center of IC interface region 11 because, as well known, any electronic components incorporated into the microneedle must be atop undoped silicon.
- EDP ethyleneidamine pyrocatacol and water
- Masking layer 47 is then removed, and a 400 nanometer (nm) thick layer 54 of Si0 2 is thermally grown on the wafer.
- a 600 nm low-stress nitride layer 56 is then deposited by low pressure chemical vapor deposition (LPCVD) for passivation. As well known, CVD will deposit on all exposed surfaces of the wafer. Silicon dioxide layer 54 will serve as a thermal barrier underneath the microheater as well as an electronic insulation layer. Silicon nitride layer 56 serves as the bottom layer of the microchannel.
- a 600 nm- thick LPCVD phosphorus-doped polycrystalline silicon layer 58 is then deposited, and the resulting structure is as shown in FIGS. 3B-1 and 3B-2.
- Polysilicon layer 58 is patterned and etched to define polysilicon heating resistors 60 on interface region 11 (FIG. 3C-1) and, if desired, polysilicon detector resistors 62 (FIG. 3C-2) . Note that phosphorus-doped polycrystalline silicon layer 58 is also etched away on backside 50. Resistors 60 are shown perpendicular to the length of channel 78; however, they may also be fabricated such that they extend lengthwise parallel to channel 78 or in any other orientation under the area of fluid flow. Resistors 60 are approximately 50 ⁇ m long. Detector resistors 62 extend lengthwise along shaft 14 and function as wires to relay a signal from electrodes or recording sites 84 (FIG.
- heating resistors 60 and detector resistors 62 are approximately .5 ⁇ m high, and 2 ⁇ m wide. Heating resistors 60 are approximately 50 ⁇ m long. The length of detector resistors 62 depends upon the eventual length of shaft 14. However, resistors 62 should reach the tip of the needle so that electrodes or recording sites may also be at the needle tip 86.
- a thin layer 64 of approximately 150 nm of LPCVD low-stress nitride is deposited to cover and protect polysilicon resistors 60 and 62 during subsequent EDP
- LTO low-temperature oxide
- the LTO layer on top of the PSG gives better adhesion to photoresist.
- the LTO layer also desirably minimizes hydrofluoric acid
- the microflow channel is then patterned and wet- etched in a 5:1 solution of buffered HF, as shown in FIGS. 3E-1 AND 3E-2.
- the buffered HF etches both PSG 66 and LTO 68 layers as shown.
- the primary configuration of the channel is formed by this etch.
- a .5 ⁇ m LTO layer 71 (FIGS. 3F-1 and 3F-2) is then deposited by
- LTO layer 71 is then patterned and wet-etched in 5:1 BHF (buffered hydrofluoric acid) to provide an etch channels area 70 as shown in FIG. 3F- 1. Dry-etching is also possible for this step.
- LTO layer 71 is also deposited on backside 50, but is not shown because they it is removed after the BHF wet-etch.
- the etch channels area 70 is advantageously only about .5 ⁇ m thick because it will be relatively easy to fill etch holes later in the fabrication process, as will become apparent below.
- Etch access holes 74 and distal 18 and shank 22 fluid ports are defined and etched in a plasma etcher through silicon nitride layer 72.
- the etch access holes lead to the sacrificial PSG and LTO layers which will be etched.
- the cross-section appears as in FIG. 3G-1; the etch access holes are not visible in FIG. 3G-2.
- Etch access holes are formed along the length of the shaft 14 in etch channel area 70, and are located every 25 ⁇ m.
- the duration of the sacrificial-layer etching step is thus independent of channel length.
- the etch access holes are approximately 5 ⁇ m x 5 ⁇ m.
- Fluid ports 18 and 22 will permit flow of a liquid through the microchannel 78 when the needle is fully operational.
- the fluid ports are approximately 20 ⁇ m x 20 ⁇ m.
- distal fluid port 18 is positioned 150 ⁇ m up the microneedle from the tip 86. Since the PSG and LTO layers are underneath nitride layer 72,. resistors 60 and 62 will not be affected by this etch.
- the fluid ports are relatively large as compared to the etch access holes, the fluid ports will not be completely filled during deposition of silicon nitride sealing layer 76, in which etch access holes are sealed (described below) .
- the fluid ports may be etched after the sacrificial PSG and LTO layers are removed from within the microchannel if good process control is employed.
- this method has the possible drawback of affecting silicon nitride 64, which protects resistors 60 and 62. Since layer 64 is approximately 150 nm, the resistors will not be affected because the etch will remove about 50 nm of layer 64.
- resistors 60 and 62 may be located so that they will not be underneath the fluid ports.
- the wafer is immersed in concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72. Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF. The resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
- concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72.
- Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF.
- the resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
- All etch access holes 74 are sealed by deposition of an additional 1.5 ⁇ m thick layer 76 of LPCVD low- stress nitride to form a shell 26, as shown in FIGS. 31- 1 and 31-2. Since the thickness of the PSG before etching was only about .5 ⁇ m underneath the etch access holes 74, a 1.5 ⁇ m deposition of silicon nitride insures that the hole will be completely filled. Microchannel 78 is thus completely sealed, except for the fluid ports. Fluid ports 18 and 22 are sufficiently wide that they will not be sealed by deposition of the 1.5 ⁇ m silicon nitride sealing layer. The size of the fluid ports is somewhat reduced during this step, but they remain sufficiently large enough to permit adequate fluid flow. A thin layer 76 of silicon nitride is also deposited in channel 78, as shown.
- channel 78 without including etch access holes 74 by using the fluid ports to remove the sacrificial PSG and LTO layers.
- this approach would require more time to fully evacuate the channel.
- a clear advantage would be that the previous sealing step could be omitted.
- EDP etch pre-openings or windows 80 are patterned by a mask and plasma etched in order to facilitate final separation of microneedle 10 from the rest of the wafer, as shown in FIGS. 3J-1 and 3J-2.
- Etch windows 80 are stopped at the 400 nm-thick Si0 2 layer 54. The etch windows will facilitate removal of the microneedle from the wafer during subsequent backside etch.
- an electrode hole 82 is formed by patterning and plasma-etching down to the 600 nm-thick phosphorus-doped polycrystalline silicon layer 58 to permit electrical contact with resistors 62. Only a single electrode hole 82 is shown in FIG. 3K-2 (the electrode is not visible in FIG. 3K-1) , but the process for fabricating contact pads 36 (see FIG. IC) is identical and is performed at the same time as electrode fabrication.
- the electrodes function as recording sites at distal end 20 and permit monitoring of biological electrical activity, as will be discussed below.
- the contact pads permit coupling of electronics with heating resistors 62.
- electrode hole 82 After electrode hole 82 is formed, a thin layer of titanium is deposited, followed by a thicker layer of platinum which completely fills the hole, forming a complete electrode 84 as shown in FIG. 3L-1. Again, the electrode is not visible in FIG. 3L-2.
- microneedle 10 is essentially complete and must now be partially separated from wafer 46.
- the backside of the wafer is patterned with a blank mask and without alignment to open the etching areas of individual die to free the microneedles from the wafer backside.
- the mask is positioned so that the microneedle tip extends to the blank center of the mask.
- Shank end 12 is covered by the mask and is not etched, but distal end 18 is not covered by the mask and so end 18 is completely etched.
- a timed EDP etch reduces the silicon wafer thickness to 120 ⁇ m, as shown in FIGS. 3M-1 and 3M-2.
- Pre-EDP etch window 80 is thus deepened so that it extends to undoped silicon layer 46.
- the microneedle is then partially separated from the wafer, and remains attached through support beams 44, best shown in FIG. 2A. Since the many microneedles fabricated on wafer remain attached to the wafer, it is easier to package, transport, and handle the needles than if they were fully freed by the anisotropic etch. When a free-standing microneedle is desired, the microneedle is simply detached from the rest of the wafer by using, for example, tweezers or some other similar implement to apply pressure to beams 44. When the beams are broken, the microneedle is freed from the wafer.
- FIG. 4A shows a simplified view of resistor 60 and contact pads 36 (also FIG. IC) of microneedle 10 (not shown) .
- the contact pads and resistor are defined on a single-doped polysilicon layer.
- a silicon dioxide layer 54 separates silicon substrate 46 and the contact pads and resistor.
- Resistor 60 functions as a microheater when a voltage source 30 supplies current to contact pads 36.
- the resistors propel a liquid to distal fluid port 18, as explained below.
- FIG. 4B illustrates the positioning of microneedle shell 26 above resistors 60.
- Si0 2 layer 54 acts as an insulator.
- the temperature of undoped silicon substrate 46 remains at the ambient temperature.
- the heaters are especially advantageous if a chemical reaction occurs quickly in response to heat. The reaction may occur in the microneedle and then may be quickly delivered to the appropriate tissue.
- a single resistor is shown in FIGS. 4A and 4B to illustrate its positioning.
- five resistors 60 form a thermally-driven cascaded bubble pump (FIG. 2A) .
- the resistor furthest from the needle tip is heated and produces a single vapor bubble.
- the adjacent resistor is heated and the bubble is moved sequentially down the line of resistors toward the distal end of the needle shaft.
- the resistors are heated quickly and sequentially, so that precise fluid control is possible. If a cascaded bubble pump is not employed, a fluid may move down the needle shaft simply by means of gravity.
- micropumps and microvalves may be incorporated onto the microneedle.
- the resistors may also be part of a bubble-powered micropump coupled to an actuator.
- the bubble generation system creates individual, spherical vapor bubbles from 2 to 500 ⁇ m in diameter by locally heating a fluid with a thin film resistor.
- Prior research has shown that microbubbles are capable of actuating a polycrystalline silicon cantilever (See L. Lin and A.P. Pisano, "Bubble Forming on a Micro Line Heater", Proceedings of ASME Winter Annual Meeting. Micromechanical Sensors. Actuators and Systems. DSC-Vol. 32, pp. 147-163, 1991).
- micropumps can also be employed with these microneedles, such as those actuated by ultrasonic Lamb waves (See R.M. Moroney, R.M. White and R.T. Howe, "Microtransport Induced by Ultrasonic Lamb Waves,” Applied Physics letters, pp. 774-776, V59, August, 1991); piezoelectrics (See H.T.G. Van Lintel, F.C.M. Van Deol and S. Bouwstra, "A Piezoelectric Micropump Based on Micromachining of Silicon,” Sensors and Actuators. Vol. 15, pp. 153-157, 1988, and M. Esashi, S. Shoji and A.
- FIGS. 5A-5E briefly illustrate a process for fabricating a microneedle with on-chip CMOS
- CMOS and BiCMOS complementary metal-oxide semiconductor devices. Both CMOS and BiCMOS are compatible with the microneedle fabrication process. The anufacturability of an on-chip electronic interface with the microneedle is essential for a broad range of applications. The manufacturabilities of the on-chip CMOS and bipolar CMOS devices with the IC-processed microneedle increase the signal conditioning ability, which is not a possible feature in needles fabricated by other means. Formation of the microneedle itself is via the same steps illustrated in FIGS. 3A-1 to 3N-2, and the CMOS devices are fabricated using standard processes. FIGS. 5A-5E, illustrate the best mode sequence for integrating fabrication of both the microneedle and CMOS devices. FIGS.
- FIG. 5A-5E are taken along line 5-5 of FIG. 1A, although no CMOS devices are shown in FIG. 1A.
- FIG. 5A is a cross-sectional view of the partially constructed needle shaft 14 and the interface region 11. The heavily doped p-type region 52 has been formed and silicon dioxide 54 and silicon nitride 56 layers have been deposited on wafer 46, as explained in connection with FIG. 3B-1. Next, silicon dioxide 54 and silicon nitride 56 layers are removed from interface region 11, where the CMOS devices will be fabricated. CMOS fabrication then commences using standard processes, and a p-type well 90, p-type layer 92, thick Si0 2 layer 94, and n-type layer 96 are formed by known methods. Polysilicon layer 58 (see FIG. 3B-1) is then deposited and polysilicon gates 98 are defined with the same masking operation which defines polysilicon resistors 62 (see FIG. 3C-1) . The resulting structure is as shown in FIG. 5B.
- FIG. 5C shows PSG layer 66 and LTO layers 70 and 71, as in FIG. 3F-1.
- Etch access holes 74 are formed and the PSG and LTO layers are etched to form microchannel 78, as explained in conjunction with FIG. 3H-1.
- EDP etch pre-openings or windows 80 are formed as explained in connection with FIG. 3J-1, and the resulting structure is shown in FIG. 5D.
- interface region 11 is masked so that the CMOS devices will not be affected.
- CMOS device fabrication is completed when metal contacts 99 are formed which connect to p-type 92 and n-type 96 regions, as well known in the art.
- the resulting structure is as shown in FIG. 5E.
- the microneedle is then separated from the rest of the wafer, as explained in connection with FIGS. 3K-1 to 3L- 2.
- the microneedle of the present invention can be expected to have broad applications to fluid sampling, fluid delivery, and precisely located chemical-reaction stimulation.
- Microneedle 10 has successfully penetrated tissue without damage to the needle, due in part to the strong silicon backbone along the needle shaft. Since the microneedles have a thickness of approximately 70 ⁇ m (microchannel height, boron region plus single crystal region) over most of their length, they are relatively strong. Another advantage of the design of the microneedle is that during and after processing it is surrounded by regions of silicon having full wafer thickness, providing even greater strength, easy post processsing and handling.
- FIG. 6 shows a real- time blood analysis system.
- Tip 86 of microneedle 10 is inserted through tissue 100 into a blood vessel 102.
- the blood is analyzed by an on-chip blood analysis amplifier and A/D converter 104, which converts an analog signal to a digital signal for digital output 106.
- Digital output 106 is transmitted to a computer 108 for real-time computer analysis, and displayed, for example, on a cathode-ray tube. Since the diameter of shaft 14 is only approximately 50 ⁇ m, it causes minimal pain to the patient during penetration because there is little trauma to the tissue involved.
- Another possible application of the silicon-processed microneedle is administration of drugs on a long term basis. For instance, the microneedle may be implanted in a small tumor and used to administer small, concentrated doses of a drug on an extremely local level.
- microneedle 10 is inserted into neural tissue 110 such that tip region 86 is between adjacent cells 112.
- recording sites or electrodes 84 on tip 86 detect the neural response to substance 114.
- the recording sites passively detect a signal which is relayed to an amplifier 104, as discussed above. Since microneedle 10 is so small, the damage caused by penetrating brain tissue is reduced.
- recording or electrode sites 84 provide the ability to obtain real-time neural measurements. Alternatively, recording sites 84 may be used to measure neural activities or to apply an electric field, current, charge or voltage to the tissue.
- FIGS. 8A and 8B show alternative embodiments of a microneedle 120.
- the microneedle may include two or more microchannels 122 and 124 so that two different fluids may be delivered via the shaft 14.
- Microchannels 122 and 124 are formed on separate portions of a substrate, and there is no substrate between them.
- electrodes 84 may be fabricated at the end of each channel to detect tissue response to chemical delivery.
- Electronics 24 may be fabricated as necessary depending upon the number of channels, electrodes, etc.
- shank end 12 may also include a network of channels 126 for distributing a fluid for analysis. Alternatively, if a number of fluids must be mixed just before delivery, it is possible to have them mix in channels 122 and 124.
- Microneedle 10 has on-board resistive heaters 60 for bubble-pumping elements, fluid ports 18 for liquid/gas transport, and IC-interface region that can be used for future on-chip circuitry and microfluidic components.
- the process for producing the needles is advantageous because the needles are surrounded by regions of silicon having full wafer thickness. This feature simplifies post- processing, handling, and lead attachment which can be accomplished prior to freeing the microneedle by breaking support beams.
- the mask fabrication process is compatible with IC processes.
- the microneedles are sufficiently sturdy to penetrate tissue without being damaged and without significant pain to the patient. Since the microneedle may be batch fabricated, the resulting microneedle is relatively inexpensive to produce as compared to a macroneedle.
- the size of the shaft diameter may be readily controlled using known semiconductor fabrication techniques.
Abstract
This invention is an IC processed microneedle including an interface region (11), and a shaft (14). A shell defines an enclosed channel to form the shaft. The shaft has ports to permit fluid movement therethrough. Microheaters, microdetectors, and additional devices may also be fabricated on the microneedle.
Description
IC-PROCESSED MICRONEEDLES
BACKGROUND OF THE INVENTION The present invention relates generally to microneedles, and more particularly to microneedles fabricated by micromachining techniques.
As is well known, needles are used to extract samples of substances from living tissue in order to analyze the substances for diagnostic purposes, or to deliver a drug or a medicine. The majority of needles in use today are macroneedles, which have a relatively large diameter as compared to a blood cell and are on the order of millimeters (mm) . The large diameter of the macroneedle shaft has the disadvantage of possibly damaging biological tissue during penetration. Additionally, tissue penetration by the needle is often painful to the patient because of the relatively large needle diameter.
One type of spring-actuated macroneedle penetrates tissue and drops blood to a chemical detector for measurement. While this needle may be less painful to the patient because penetration is of a relatively short duration, the needle is still relatively large and may damage tissue. Additionally, neither of the above- mentioned macroneedles provide real-time blood analysis. As an alternative to macroneedles, microneedles having a diameter on the order of micrometers have many applications. For instance, they may be used as precise
injection/extraction needles in cell biology, as injection/extraction heads in a drug delivery system or microchemical factory, and as injection/extraction heads in microsurgery. It is also advantageous to have a smaller size needle because the reduced size decreases discomfort and pain to the patient. This has been demonstrated in research on electrical microprobes made of silicon for an IC-co patible multichannel neural- recording array. The research has demonstrated that silicon microprobes with cross-sections on the order of tens of micrometers can penetrate living tissue without causing significant trauma. (K. Najafi, K.D. Wise and T. Mochizuki, "A High-Yield IC-Compatible Multichannel Recording Array," IEEE Micro Trans, on Electron Devices. vol. ED-32, pp. 1206-1211, July 1985.)
Recently, microneedles have been used with an inner diameter of approximately 20 micrometers (μm) (1 μm = 1 micron = 10"6m) . These microneedles are formed by heating the end of a glass pipette and lengthening the end until the diameter is reduced to about 20 μm. Most cells in an animal such as a human measure 10-20 micrometers in diameter. Thus, while these glass microneedles can be used to insert and withdraw fluids and gasses from a single cell, it is difficult to control the size of the needle shaft during fabrication. Additionally, the resulting needle is not very strong and real-time blood analysis is not possible. Another disadvantage of glass pipette needles is that it is difficult to incorporate electronics with such needles. In view of the foregoing, an object of the present invention is to provide a microneedle having controllable and relatively small dimensions, including shaft width, and a method for making the same.
Another object of the present invention is to provide a microneedle which permits real-time analysis of a fluid being sampled.
Yet another object of the present invention is to provide a microneedle which minimizes the amount of trauma to the tissue being penetrated.
Still another object of the present invention is to provide a microneedle which may be mass produced.
Yet still another object of the present invention is to provide a microneedle which is strong enough to reliably penetrate biological tissue.
A further object of the present invention is to provide a microneedle which may incorporate micropumps, microvalves and microdetectors.
Additional objects and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention may be realized and obtained by means of the instrumentalities and combinations particularly pointed out in the claims.
SUMMARY OF THE INVENTION
The present invention is directed to an IC- processed microneedle formed from a substrate which defines an interface region and an elongated portion extending away from the interface region. A shaft is formed from the elongated region by a shell, which defines an enclosed channel within the shaft. One end of the shaft is attached to the interface region. The shaft includes ports which permit fluid to flow through the microneedle. The method of the present invention includes a sequence of steps for forming an IC-processed microneedle. First, a substrate is provided for forming an interface region and an elongated portion extending away from the interface region. A patterned non-planar etchable structure is then formed on the frontside of the elongated portion of the substrate. An unetchable
membrane layer is deposited atop the etchable structure, and etching holes are opened in the membrane layer. One of the etching holes is at an end of the membrane layer and a second etching hole is positioned at a second end of the membrane layer. Next, the etchable structure is etched to a predetermined extent to form a cavity underneath the membrane layer, thereby producing a shaft formed from the membrane layer and the elongated portion of said substrate.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings, which are incorporated in and constitute a part of the specification, schematically illustrate a preferred embodiment of the invention and, together with the general description given above and the detailed description of the preferred embodiment given below, serve to explain the principles of the invention.
Figure 1A is a perspective view of an embodiment of a silicon processed microneedle. Figure IB is a cross-sectional view of the microneedle as taken along line IB-IB of Figure 1A.
Figure IC is a cross-sectional view of the microneedle as taken along line 1C-1C of Figure 1A.
Figure 2A is a plan view of the microneedle prior to detachment from the substrate.
Figure 2B is a cross-sectional view of the microneedle as taken along line 2B-2B of Figure 2A.
Figures 3A-1 to 3N-2 schematically illustrate a microneedle fabrication process according to the present invention. The left-hand figures are taken along line 3L-3L of Figure 1A, and the right-hand figures are taken along line 3R-3R.
Figures 4A and 4B are views illustrating a icroheater and its positioning relative to the microchannel, respectively.
Figures 5A-5E show the sequence of steps in fabricating the microneedle with on-chip CMOS (complementary metal-oxide semiconductor) as taken along line 5-5 of Figure lA. Figure 6 is a schematic diagram showing the microneedle penetrating tissue in a first application of the present invention.
Figure 7 is a schematic diagram including a detailed portion showing the microneedle penetrating tissue in another application of microneedle use.
Figures 8A and 8B show alternative embodiments of the microneedle.
DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention will be described in terms of the preferred embodiment. The preferred embodiment is an apparatus and method for fabricating IC-processed microneedles. Referring in detail to th- drawings, wherein like reference numerals designate like parts in several figures, and initially to FIG. 1A, a microneedle 10 in accordance with the present invention is illustrated.
Microneedle 10 includes an interface region 11 and a shaft 14 having a icroflow channel 78 therein along its length. A distal end 20 of shaft 14 can be inserted into tissue (not shown) so that liquids
(including gases) may be delivered to or taken from a patient, for example, via a distal fluid port 18. A shank fluid port 22 is located on shank or proximal end 12 of shaft 14 to deliver or receive fluids. The microneedle may include more than two ports, as desired. Microflow channel 78 runs along the length of fully- enclosed microneedle shaft 14. A series of thin polysilicon heating resistors 60 are located on interface region 11 along the floor of microflow channel 78. Interface region 11 is sufficiently thick to permit incorporation of on-chip electronics 24 for real-time
fluid analysis. Heating resistors 60 may be used to form a thermally-driven, cascaded-bubble icropump or simple heater. The microneedle may also include detector resistors 62 which extend along the bottom of the icrochannel (see FIG. IB) and are coupled to electrodes 84 (FIG. 3L-2) on the tip 86 of the needle. Microflow channel 78 is formed by removing sacrificial layers from underneath a shell 26 during processing. In order to access the sacrificial layer, etch access holes 74 are opened and then filled after etching. The fabrication procedures will be discussed below in . relation to FIGS. 3A-1 through 3N-2.
FIG. IB shows a cross-section of fully-enclosed microflow channel 78. The channel height is approximately 9 μm, and is indicated by dimension "G" , and the channel width "H" may be between 30 μm to 60 μm. The needle height "I" is about 70 μm, and the needle width "J" is approximately 80 μm at the tip region. FIG. IC illustrates the positioning of a polysilicon resistor 60 on interface region 11. Contact pads 36 are situated on both sides of the microflow channel 78 at shank end 12 and provide an outside connection to resistors 60, which function as microheaters. Note that detector resistors 62 cannot be seen in FIG. IC because this cross-section is taken along line 1C-1C on the interface region. The detector resistors extend along the length of the channel but do not extend into the interface region any further than is necessary to couple them to electronics 24. The location of both resistors can be best seen in FIG. 3N- 2.
FIG. 2A is a plan view of a microneedle 10 before it is separated from wafer or substrate 46 by breaking beams 44. Support beams 44 connect microneedle 10 to substrate 46 and facilitate testing and manipulation of the microneedle prior to its final use. Although only a single microneedle 10 is shown, many microneedles may be
fabricated on a single wafer. Area 40 marks the area where microneedle 10 will be separated from substrate or thin-film 46. Interface region 11 may be used as an integrated-circuit (IC) interface region of approximately 2 to 3 millimeters (mm)2. The tip region 86 is formed at an angle θ of approximately 45° to the plane of the needle shaft 14, to form a sharp triangular tip 87. The width of the interface region, indicated by dimension "X", is approximately 1.5 mm, and the length of the shaft, indicated by dimension "Y", is between 1 and 6 mm. At shank end 12, interface region 11 widens out to a large surface area, suitable for incorporation of additional integrated electronic and/or fluidic devices. Cross-sectional dimensions of a completed microneedle 10 are shown in FIG. 2B after if has been detached from wafer 46. Wafer 46 has an initial thickness of between 500 and 550 μm, as indicated by "Z". The wafer thickness of the microneedle is reduced during fabrication. Shaft 14 has a thickness of approximately 50 μm indicated by dimension "I". In microneedles which are 3 mm-long or longer, microneedle 10 tapers from the tip end 86, where it is approximately 80 μm wide, to 140 μm, where it joins the shank in order to increase strength. The retained single-crystal silicon layer 46 provides a rigid spine which adds strength to the needle. Note that there is no single- crystal silicon at the tip region 86, so that the tip is sharper and smaller than the portion of the shaft including single-crystal silicon.
The fabrication sequence for formation of a microneedle is shown in FIGS. 3A-1 to 3N-2. Seven masks may be used. The drawings are not to scale, and dimensions should be taken from the text; the drawings are to illustrate the process, and not necessarily the preferred dimensions of the microneedle. The microneedle is formed using IC (integrated circuit)
processing methods, e.g. oxidation, lithography, chemical vapor deposition, doping, and etching. Briefly, microchannel 78 is surface-micro achined onto a single-crystal silicon substrate or thin-film 46 that is mostly etched from the wafer backside along shaft 14 in the final fabrication step. While only a single microneedle is shown in the following steps, it will be understood that many microneedles may be fabricated simultaneously on a single wafer. FIGS. 3A-1 AND 3A-2 show a <100>-oriented lightly doped n-type silicon wafer 46 which is 500-550 μm thick. A thick masking layer 47 of silicon dioxide (Si02) 1.2 μm thick is thermally grown on wafer frontside 48 and backside 50. Masking layer 47 is patterned as shown, and boron is diffused at approximately 1125 °C for fifteen hours to form a 12 μm-deep heavily doped p-type region 52. Both the future interface region 11 and shaft 14 are indicated generally in these figures. Boron-doped region 52 defines tip region 84 (FIG. 2A) , extends along the needle shaft and defines the perimeter of interface region 11, as best shown in FIG. 2A. Boron-doped region 52 acts as an etchant stop since EDP (ethyleneidamine pyrocatacol and water) , used during fabrication, does not etch boron-doped silicon. Note that the boron-doped region is omitted from the center of IC interface region 11 because, as well known, any electronic components incorporated into the microneedle must be atop undoped silicon.
Masking layer 47 is then removed, and a 400 nanometer (nm) thick layer 54 of Si02 is thermally grown on the wafer. A 600 nm low-stress nitride layer 56 is then deposited by low pressure chemical vapor deposition (LPCVD) for passivation. As well known, CVD will deposit on all exposed surfaces of the wafer. Silicon dioxide layer 54 will serve as a thermal barrier underneath the microheater as well as an electronic insulation layer. Silicon nitride layer 56 serves as
the bottom layer of the microchannel. Next, a 600 nm- thick LPCVD phosphorus-doped polycrystalline silicon layer 58 is then deposited, and the resulting structure is as shown in FIGS. 3B-1 and 3B-2. Polysilicon layer 58 is patterned and etched to define polysilicon heating resistors 60 on interface region 11 (FIG. 3C-1) and, if desired, polysilicon detector resistors 62 (FIG. 3C-2) . Note that phosphorus-doped polycrystalline silicon layer 58 is also etched away on backside 50. Resistors 60 are shown perpendicular to the length of channel 78; however, they may also be fabricated such that they extend lengthwise parallel to channel 78 or in any other orientation under the area of fluid flow. Resistors 60 are approximately 50 μm long. Detector resistors 62 extend lengthwise along shaft 14 and function as wires to relay a signal from electrodes or recording sites 84 (FIG. 2A) to the shank end of the channel, where electronics 24 process the signals. There is one resistor for each electrode and so the width of channel 78 determines the number of electrodes which may be fabricated within the channel. The microneedle shown has two resistors, but more electrodes could be incorporated into the microneedle by widening the channel or altering the aspect ratio of the resistors. Both heating resistors 60 and detector resistors 62 are approximately .5 μm high, and 2 μm wide. Heating resistors 60 are approximately 50 μm long. The length of detector resistors 62 depends upon the eventual length of shaft 14. However, resistors 62 should reach the tip of the needle so that electrodes or recording sites may also be at the needle tip 86.
Referring now to FIGS. 3D-1 and 3D-2, a thin layer 64 of approximately 150 nm of LPCVD low-stress nitride is deposited to cover and protect polysilicon resistors 60 and 62 during subsequent EDP
(ethyleneidamine pyrocatacol and water) etching. A layer 66 of 5 μm phosphosilicate glass (PSG) is
deposited by LPCVD process and then an approximately 3 μm layer 68 of a low-temperature oxide (LTO) such as undoped LPCVD Si02 is deposited. The LTO layer on top of the PSG gives better adhesion to photoresist. The LTO layer also desirably minimizes hydrofluoric acid
(HF) attack on the interface between the photoresist and PSG. Furthermore, no high-temperature densification process is needed so that the future circuitry in the IC interface region 11 will not be damaged. The microflow channel is then patterned and wet- etched in a 5:1 solution of buffered HF, as shown in FIGS. 3E-1 AND 3E-2. The buffered HF etches both PSG 66 and LTO 68 layers as shown. The primary configuration of the channel is formed by this etch. A .5 μm LTO layer 71 (FIGS. 3F-1 and 3F-2) is then deposited by
LPCVD to provide an area for future etch access holes. The resulting shell formed from LTO layers 68 and 71 is approximately 3-4 μm. LTO layer 71 is then patterned and wet-etched in 5:1 BHF (buffered hydrofluoric acid) to provide an etch channels area 70 as shown in FIG. 3F- 1. Dry-etching is also possible for this step. LTO layer 71 is also deposited on backside 50, but is not shown because they it is removed after the BHF wet-etch. The etch channels area 70 is advantageously only about .5 μm thick because it will be relatively easy to fill etch holes later in the fabrication process, as will become apparent below.
The wafer is then coated with a 1 μm thick layer 72 of LPCVD low-stress silicon nitride which will become a portion of the microchannel shell 26 (FIG. IB) . Etch access holes 74 and distal 18 and shank 22 fluid ports are defined and etched in a plasma etcher through silicon nitride layer 72. The etch access holes lead to the sacrificial PSG and LTO layers which will be etched. The cross-section appears as in FIG. 3G-1; the etch access holes are not visible in FIG. 3G-2. Etch access holes are formed along the length of the shaft 14 in
etch channel area 70, and are located every 25 μm. The duration of the sacrificial-layer etching step is thus independent of channel length. The etch access holes are approximately 5μm x 5μm. Fluid ports 18 and 22 will permit flow of a liquid through the microchannel 78 when the needle is fully operational. The fluid ports are approximately 20 μm x 20 μm. In a preferred embodiment, distal fluid port 18 is positioned 150 μm up the microneedle from the tip 86. Since the PSG and LTO layers are underneath nitride layer 72,. resistors 60 and 62 will not be affected by this etch. Additionally, because the fluid ports are relatively large as compared to the etch access holes, the fluid ports will not be completely filled during deposition of silicon nitride sealing layer 76, in which etch access holes are sealed (described below) . As an alternative, the fluid ports may be etched after the sacrificial PSG and LTO layers are removed from within the microchannel if good process control is employed. However, this method has the possible drawback of affecting silicon nitride 64, which protects resistors 60 and 62. Since layer 64 is approximately 150 nm, the resistors will not be affected because the etch will remove about 50 nm of layer 64. As another alternative, resistors 60 and 62 may be located so that they will not be underneath the fluid ports.
After the etch access holes and fluid ports have been formed, the wafer is immersed in concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72. Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF. The resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
All etch access holes 74 are sealed by deposition of an additional 1.5 μm thick layer 76 of LPCVD low-
stress nitride to form a shell 26, as shown in FIGS. 31- 1 and 31-2. Since the thickness of the PSG before etching was only about .5 μm underneath the etch access holes 74, a 1.5 μm deposition of silicon nitride insures that the hole will be completely filled. Microchannel 78 is thus completely sealed, except for the fluid ports. Fluid ports 18 and 22 are sufficiently wide that they will not be sealed by deposition of the 1.5 μm silicon nitride sealing layer. The size of the fluid ports is somewhat reduced during this step, but they remain sufficiently large enough to permit adequate fluid flow. A thin layer 76 of silicon nitride is also deposited in channel 78, as shown.
It is possible to form channel 78 without including etch access holes 74 by using the fluid ports to remove the sacrificial PSG and LTO layers. However, this approach would require more time to fully evacuate the channel. A clear advantage would be that the previous sealing step could be omitted. The needle has now been substantially fabricated, and steps to separate it from the wafer are now taken. EDP etch pre-openings or windows 80 are patterned by a mask and plasma etched in order to facilitate final separation of microneedle 10 from the rest of the wafer, as shown in FIGS. 3J-1 and 3J-2. Etch windows 80 are stopped at the 400 nm-thick Si02 layer 54. The etch windows will facilitate removal of the microneedle from the wafer during subsequent backside etch. It will be desirable later to remove both layers 54 and 56 in order to separate the microneedle. However, the etch is stopped at layer 54 at this point because it is relatively easy to etch silicon dioxide and relatively difficult to etch silicon nitride. Thus, silicon nitride layer 56 is removed from the frontside prior to backside etching.
Next, an electrode hole 82 is formed by patterning and plasma-etching down to the 600 nm-thick
phosphorus-doped polycrystalline silicon layer 58 to permit electrical contact with resistors 62. Only a single electrode hole 82 is shown in FIG. 3K-2 (the electrode is not visible in FIG. 3K-1) , but the process for fabricating contact pads 36 (see FIG. IC) is identical and is performed at the same time as electrode fabrication. The electrodes function as recording sites at distal end 20 and permit monitoring of biological electrical activity, as will be discussed below. The contact pads permit coupling of electronics with heating resistors 62. After electrode hole 82 is formed, a thin layer of titanium is deposited, followed by a thicker layer of platinum which completely fills the hole, forming a complete electrode 84 as shown in FIG. 3L-1. Again, the electrode is not visible in FIG. 3L-2.
At this point, microneedle 10 is essentially complete and must now be partially separated from wafer 46. The backside of the wafer is patterned with a blank mask and without alignment to open the etching areas of individual die to free the microneedles from the wafer backside. In a preferred fabrication method, the mask is positioned so that the microneedle tip extends to the blank center of the mask. Shank end 12 is covered by the mask and is not etched, but distal end 18 is not covered by the mask and so end 18 is completely etched. A timed EDP etch reduces the silicon wafer thickness to 120 μm, as shown in FIGS. 3M-1 and 3M-2. After rinsing in de-ionized water, the wafer is immersed in a 5:1 BHF solution which attacks only the pre-opened, bare Si02 layer 54. Pre-EDP etch window 80 is thus deepened so that it extends to undoped silicon layer 46.
Immersion in an EDP timed etch reduces the 120 μm thickness to 50 μm at shank end 12 as shown in FIGS. 3N- 1 and 3N-2. As also shown in FIG. 2B, tip region 86 of shaft 14 does not contain any single-crystal silicon due to the corner-etching behavior of EDP. A combination of corner etching and etching from the crystal backside
also removes the thicker non-doped single-crystal silicon for approximately 50 μm along the needle underside from the tip end. The corner etching behavior of EDP is addressed by B. Bassous in "Fabrication of Novel Three-Dimensional Microstructures by the
Anisotropic Etching of (100) and (110) Silicon, ", IEEE Trans, on Electron Devices. Vol. Ed-25, No. 10, Oct. 1978.
The microneedle is then partially separated from the wafer, and remains attached through support beams 44, best shown in FIG. 2A. Since the many microneedles fabricated on wafer remain attached to the wafer, it is easier to package, transport, and handle the needles than if they were fully freed by the anisotropic etch. When a free-standing microneedle is desired, the microneedle is simply detached from the rest of the wafer by using, for example, tweezers or some other similar implement to apply pressure to beams 44. When the beams are broken, the microneedle is freed from the wafer.
FIG. 4A shows a simplified view of resistor 60 and contact pads 36 (also FIG. IC) of microneedle 10 (not shown) . As explained above, the contact pads and resistor are defined on a single-doped polysilicon layer. A silicon dioxide layer 54 separates silicon substrate 46 and the contact pads and resistor. Resistor 60 functions as a microheater when a voltage source 30 supplies current to contact pads 36. The resistors propel a liquid to distal fluid port 18, as explained below. FIG. 4B illustrates the positioning of microneedle shell 26 above resistors 60. As noted above, since there is a silicon dioxide layer 54 underneath the polysilicon heater, heat conduction from the heater to silicon substrate 46 is restricted because Si02 layer 54 acts as an insulator. Due to the low power dissipated in the heater, the temperature of undoped silicon substrate 46 remains at the ambient
temperature. The heaters are especially advantageous if a chemical reaction occurs quickly in response to heat. The reaction may occur in the microneedle and then may be quickly delivered to the appropriate tissue. A single resistor is shown in FIGS. 4A and 4B to illustrate its positioning. However, in a preferred embodiment five resistors 60 form a thermally-driven cascaded bubble pump (FIG. 2A) . In operation, the resistor furthest from the needle tip is heated and produces a single vapor bubble. Then, the adjacent resistor is heated and the bubble is moved sequentially down the line of resistors toward the distal end of the needle shaft. The resistors are heated quickly and sequentially, so that precise fluid control is possible. If a cascaded bubble pump is not employed, a fluid may move down the needle shaft simply by means of gravity.
In addition to resistors, micropumps and microvalves (neither is shown) may be incorporated onto the microneedle. For example, the resistors may also be part of a bubble-powered micropump coupled to an actuator. As discussed above, the bubble generation system creates individual, spherical vapor bubbles from 2 to 500 μm in diameter by locally heating a fluid with a thin film resistor. Prior research has shown that microbubbles are capable of actuating a polycrystalline silicon cantilever (See L. Lin and A.P. Pisano, "Bubble Forming on a Micro Line Heater", Proceedings of ASME Winter Annual Meeting. Micromechanical Sensors. Actuators and Systems. DSC-Vol. 32, pp. 147-163, 1991). Other micropumps can also be employed with these microneedles, such as those actuated by ultrasonic Lamb waves (See R.M. Moroney, R.M. White and R.T. Howe, "Microtransport Induced by Ultrasonic Lamb Waves," Applied Physics letters, pp. 774-776, V59, August, 1991); piezoelectrics (See H.T.G. Van Lintel, F.C.M. Van Deol and S. Bouwstra, "A Piezoelectric Micropump Based on Micromachining of Silicon," Sensors and Actuators.
Vol. 15, pp. 153-157, 1988, and M. Esashi, S. Shoji and A. Nakano, "Normally Closed Microvalve and Micropump Fabricated on a Silicon Wafer," Sensors and Actuators. Vol. 20, pp. 163-169, Nov. 1989); and electrohydrodynamics (See S. F. Bart, L. S. Tavrow, M. Mehregany and J. H. Lang, "Microfabricated Electrohydrodynamic Pumps," Sensors and Actuators, Vol. 21, Nl-3, pp. 193-197, Feb. 1990).
FIGS. 5A-5E briefly illustrate a process for fabricating a microneedle with on-chip CMOS
(complementary metal-oxide semiconductor) devices. Both CMOS and BiCMOS are compatible with the microneedle fabrication process. The anufacturability of an on- chip electronic interface with the microneedle is essential for a broad range of applications. The manufacturabilities of the on-chip CMOS and bipolar CMOS devices with the IC-processed microneedle increase the signal conditioning ability, which is not a possible feature in needles fabricated by other means. Formation of the microneedle itself is via the same steps illustrated in FIGS. 3A-1 to 3N-2, and the CMOS devices are fabricated using standard processes. FIGS. 5A-5E, illustrate the best mode sequence for integrating fabrication of both the microneedle and CMOS devices. FIGS. 5A-5E are taken along line 5-5 of FIG. 1A, although no CMOS devices are shown in FIG. 1A. FIG. 5A is a cross-sectional view of the partially constructed needle shaft 14 and the interface region 11. The heavily doped p-type region 52 has been formed and silicon dioxide 54 and silicon nitride 56 layers have been deposited on wafer 46, as explained in connection with FIG. 3B-1. Next, silicon dioxide 54 and silicon nitride 56 layers are removed from interface region 11, where the CMOS devices will be fabricated. CMOS fabrication then commences using standard processes, and a p-type well 90, p-type layer 92, thick Si02 layer 94, and n-type layer 96 are formed by known methods.
Polysilicon layer 58 (see FIG. 3B-1) is then deposited and polysilicon gates 98 are defined with the same masking operation which defines polysilicon resistors 62 (see FIG. 3C-1) . The resulting structure is as shown in FIG. 5B.
FIG. 5C shows PSG layer 66 and LTO layers 70 and 71, as in FIG. 3F-1. Etch access holes 74 are formed and the PSG and LTO layers are etched to form microchannel 78, as explained in conjunction with FIG. 3H-1. EDP etch pre-openings or windows 80 are formed as explained in connection with FIG. 3J-1, and the resulting structure is shown in FIG. 5D. During these operations, interface region 11 is masked so that the CMOS devices will not be affected. Next, CMOS device fabrication is completed when metal contacts 99 are formed which connect to p-type 92 and n-type 96 regions, as well known in the art. The resulting structure is as shown in FIG. 5E. The microneedle is then separated from the rest of the wafer, as explained in connection with FIGS. 3K-1 to 3L- 2.
The microneedle of the present invention can be expected to have broad applications to fluid sampling, fluid delivery, and precisely located chemical-reaction stimulation. Microneedle 10 has successfully penetrated tissue without damage to the needle, due in part to the strong silicon backbone along the needle shaft. Since the microneedles have a thickness of approximately 70 μm (microchannel height, boron region plus single crystal region) over most of their length, they are relatively strong. Another advantage of the design of the microneedle is that during and after processing it is surrounded by regions of silicon having full wafer thickness, providing even greater strength, easy post processsing and handling.
An application of the microneedle of the present invention is illustrated in FIG. 6, which shows a real-
time blood analysis system. Tip 86 of microneedle 10 is inserted through tissue 100 into a blood vessel 102. As blood is drawn into the needle via shaft 14, the blood is analyzed by an on-chip blood analysis amplifier and A/D converter 104, which converts an analog signal to a digital signal for digital output 106. Digital output 106 is transmitted to a computer 108 for real-time computer analysis, and displayed, for example, on a cathode-ray tube. Since the diameter of shaft 14 is only approximately 50 μm, it causes minimal pain to the patient during penetration because there is little trauma to the tissue involved. Another possible application of the silicon-processed microneedle is administration of drugs on a long term basis. For instance, the microneedle may be implanted in a small tumor and used to administer small, concentrated doses of a drug on an extremely local level.
Another application of the microneedle is shown in FIG. 7, in which the microneedle is used for recording neural signals. Specifically, microneedle 10 is inserted into neural tissue 110 such that tip region 86 is between adjacent cells 112. As a chemical substance 114 is delivered to neural tissue 110, recording sites or electrodes 84 on tip 86 detect the neural response to substance 114. The recording sites passively detect a signal which is relayed to an amplifier 104, as discussed above. Since microneedle 10 is so small, the damage caused by penetrating brain tissue is reduced. Additionally, recording or electrode sites 84 provide the ability to obtain real-time neural measurements. Alternatively, recording sites 84 may be used to measure neural activities or to apply an electric field, current, charge or voltage to the tissue. Processing electronics may be located separate from the interface region, as desired. Additionally, an active device may be positioned at the tip of the microneedle to process a detected signal.
FIGS. 8A and 8B show alternative embodiments of a microneedle 120. The microneedle may include two or more microchannels 122 and 124 so that two different fluids may be delivered via the shaft 14. Microchannels 122 and 124 are formed on separate portions of a substrate, and there is no substrate between them. Additionally, electrodes 84 may be fabricated at the end of each channel to detect tissue response to chemical delivery. Electronics 24 may be fabricated as necessary depending upon the number of channels, electrodes, etc. As shown in FIG. 8B, shank end 12 may also include a network of channels 126 for distributing a fluid for analysis. Alternatively, if a number of fluids must be mixed just before delivery, it is possible to have them mix in channels 122 and 124.
In summary, an apparatus and method for a IC- processed microneedle have been described. Microneedle 10 has on-board resistive heaters 60 for bubble-pumping elements, fluid ports 18 for liquid/gas transport, and IC-interface region that can be used for future on-chip circuitry and microfluidic components. The process for producing the needles is advantageous because the needles are surrounded by regions of silicon having full wafer thickness. This feature simplifies post- processing, handling, and lead attachment which can be accomplished prior to freeing the microneedle by breaking support beams. The mask fabrication process is compatible with IC processes. The microneedles are sufficiently sturdy to penetrate tissue without being damaged and without significant pain to the patient. Since the microneedle may be batch fabricated, the resulting microneedle is relatively inexpensive to produce as compared to a macroneedle. The size of the shaft diameter may be readily controlled using known semiconductor fabrication techniques.
The present invention has been described in terms of a preferred embodiment. The invention, however, is
not limited to the embodiment depicted and described. Rather, the scope of the invention is defined by the appended claims.
Claims
1. A icrostructure, comprising: a substrate; and a shell defining an enclosed channel above said substrate to form a shaft.
2. The microstructure of claim 1 wherein: said substrate defines an interface region and an elongated portion extending away from said interface region; and said shaft includes a first end at said interface region, a second end distal from said first end, and at least two ports for permitting movement of a fluid therethrough.
3. The microstructure of claim 2 further including: heating means at said first end of said shaft for heating a liquid within said shaft, whereby said liquid forms a bubble and moves within said shaft.
4. The microstructure of claim 3 wherein said heating means comprises a polysilicon resistor.
5. The microstructure of claim 2 further including: detecting means on said elongated portion for monitoring electrical activity generated by biological tissue in which said microstructure is inserted.
6. The microstructure of claim 5 wherein said detecting means is located at said second end of said shaft.
7. The microstructure of claim 5 wherein said detecting means includes: a polysilicon resistor.
8. The microstructure of claim 2 further including fluid movement means for moving a fluid along said shaft.
9. The microstructure of claim 8 wherein said fluid movement means includes: a plurality of resistors fabricated proximate each another, wherein when said resistors are heated in sequence, a vapor bubble produced is moved sequentially along said resistors.
10. The microstructure of claim 9 wherein said plurality of resistors are positioned in a line.
11. The microstructure of claim 2 wherein a first of said at least two ports is located at said first end of said shaft and a second of said at least two ports is located at said second end of said shaft.
12. The microstructure of claim 2 further including electronic components fabricated on said interface region.
13. The microstructure of claim 2 further including a plurality of end channels converging at said first end and communicating with said enclosed channel.
14. The microstructure of claim 2 wherein its elements are formed by integrated-circuit microfabrication methods.
15. An microneedle, comprising: an interface region having an area of 2 to 3 millimeters square; and an elongated hollow shaft connected to and extending from said interface region for permitting movement of a fluid therethrough, said shaft having a length of between about 1 and 6 millimeters, said shaft having at a distal end a width of about 50 micrometers or less and a height of about 9 micrometers or less.
16. The microneedle of claim 15 further including at least one resistor located within said shaft for heating a fluid to form a bubble that moves along said shaft.
17. A method of fabricating a microstructure, comprising the steps of: providing a substrate for forming an interface region and an elongated portion extending away from said interface region, said substrate including a frontside and a backside; forming a patterned, non-planar etchable structure on the frontside of said elongated portion; depositing an unetchable membrane layer atop said etchable structure; opening at least one etching hole in said membrane layer; and etching said etchable structure by placing an etchant into said etching hole, said etchable structure being etched to a predetermined extent to form a cavity underneath said membrane layer, thereby producing a shaft formed from said membrane layer and said elongated portion of said substrate.
18. The method of claim 17 further including the step of: depositing additional membrane material to close said at least one etching hole.
19. The method of claim 17 wherein said opening step includes opening a plurality of etching holes including a first etching hole at a first end of said membrane layer and a second etching hole at a second end of said membrane layer
20. The method of claim 19 wherein said depositing step includes: depositing additional membrane material to close said plurality of etching holes except said first and second etching holes, which form ports for permitting flow of a liquid therethrough.
21. The method of claim 17 further including the step of: prior to said step of forming said patterned non- planar etchable structure, forming at least one polysilicon resistor, such that said patterned non- planar etchable structure is then deposited atop said resistor.
22. The microstructure fabricated by the method of claim 17.
23. The method of claim 17 further including the steps of: patterning the backside of said substrate; and etching the backside in order to separate said shaft and said interface region from said substrate.
24. The method of claim 23 wherein said backside etching step further includes the steps of : etching the backside to a predetermined extent such that said interface region and said elongated portion remain attached to said substrate; etching portions of thin films on the frontside of said substrate to form an opening through to said substrate; and etching said substrate such that said opening extends through said substrate on said elongated portion, said elongated portion being detached from said substrate.
25. A method of fabricating a microneedle, comprising the steps of: providing a semiconductor substrate for forming an interface region and an elongated portion; forming a shaft enclosing a microchannel along said elongated portion, said shaft extending from said interface region; and forming first and second ports through said shaft for permitting transport of liquids through said microchannel.
26. The method of claim 25 further including the step of: providing a first resistor on said substrate within said shaft for heating liquids which flow therethrough.
27. The method of claim 26 further including the step of: fabricating a CMOS device on said interface region.
28. The method of claim 27 wherein said CMOS fabricating step includes depositing a polysilicon layer, said polysilicon layer also forming said first resistor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU29072/95A AU2907295A (en) | 1994-06-06 | 1995-06-06 | Ic-processed microneedles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/254,328 | 1994-06-06 | ||
US08/254,328 US5591139A (en) | 1994-06-06 | 1994-06-06 | IC-processed microneedles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995033504A1 true WO1995033504A1 (en) | 1995-12-14 |
Family
ID=22963860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/007916 WO1995033504A1 (en) | 1994-06-06 | 1995-06-06 | Ic-processed microneedles |
Country Status (3)
Country | Link |
---|---|
US (2) | US5591139A (en) |
AU (1) | AU2907295A (en) |
WO (1) | WO1995033504A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999041606A1 (en) * | 1998-02-16 | 1999-08-19 | Stichting Voor Fundamenteel Onderzoek Der Materie | Microdialysis-probe integrated with a si-chip |
WO2002049507A1 (en) | 2000-12-19 | 2002-06-27 | Inverness Medical Limited | Analyte measurement |
EP1267159A2 (en) * | 2001-06-11 | 2002-12-18 | Bayer Corporation | Electrochemical sensor and method of making |
EP1911394A1 (en) * | 2006-10-14 | 2008-04-16 | Roche Diagnostics GmbH | Lancet with capillar channel |
EP1967581A1 (en) * | 2007-03-08 | 2008-09-10 | Interuniversitair Microelektronica Centrum | CMOS compatible microneedle structures |
US8298487B2 (en) | 2000-12-12 | 2012-10-30 | Bayer Healthcare Llc | Method of forming an electrochemical sensor |
EP2708889A1 (en) * | 2012-09-12 | 2014-03-19 | Universität Leipzig | Method and device for obtaining a tissue sample and for characterizing the tissue sample by determining at least one electrical property |
US9551698B2 (en) | 2009-12-30 | 2017-01-24 | Imec | Microneedle |
Families Citing this family (380)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6007676A (en) * | 1992-09-29 | 1999-12-28 | Boehringer Ingelheim International Gmbh | Atomizing nozzle and filter and spray generating device |
US7235056B2 (en) * | 1996-05-17 | 2007-06-26 | Amira Medical | Body fluid sampling device and methods of use |
US7828749B2 (en) | 1996-05-17 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
US7666150B2 (en) * | 1996-05-17 | 2010-02-23 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
EP1579814A3 (en) | 1996-05-17 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US20020010406A1 (en) * | 1996-05-17 | 2002-01-24 | Douglas Joel S. | Methods and apparatus for expressing body fluid from an incision |
KR100232998B1 (en) * | 1996-06-05 | 1999-12-01 | 윤종용 | Chemical bath unit with controlling means for etch rate |
DE69823904T2 (en) * | 1997-03-20 | 2005-06-16 | F. Hoffmann-La Roche Ag | Micromechanical pipetting device |
US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
DE19742439C1 (en) * | 1997-09-26 | 1998-10-22 | Boehringer Ingelheim Int | Fluid micro-filter |
US6036924A (en) * | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6106751A (en) | 1998-03-18 | 2000-08-22 | The Regents Of The University Of California | Method for fabricating needles via conformal deposition in two-piece molds |
US6391005B1 (en) * | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
AU2004200303B2 (en) * | 1998-06-10 | 2007-10-18 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
EP1086214B1 (en) * | 1998-06-10 | 2009-11-25 | Georgia Tech Research Corporation | Microneedle devices and methods of their manufacture |
US7344499B1 (en) | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
GB9815819D0 (en) * | 1998-07-22 | 1998-09-16 | Secr Defence | Transferring materials into cells and a microneedle array |
GB9815820D0 (en) * | 1998-07-22 | 1998-09-16 | Secr Defence | Improvements relating to micro-machining |
US6100107A (en) * | 1998-08-06 | 2000-08-08 | Industrial Technology Research Institute | Microchannel-element assembly and preparation method thereof |
US6010461A (en) * | 1998-09-01 | 2000-01-04 | Sitek, Inc. | Monolithic silicon intra-ocular pressure sensor and method therefor |
CA2344398A1 (en) * | 1998-09-18 | 2000-03-30 | The University Of Utah | Surface micromachined microneedles |
US7048723B1 (en) | 1998-09-18 | 2006-05-23 | The University Of Utah Research Foundation | Surface micromachined microneedles |
WO2000042233A1 (en) * | 1999-01-13 | 2000-07-20 | Cornell Research Foundation, Inc. | Monolithic fabrication of fluidic structures |
US6314317B1 (en) * | 1999-02-18 | 2001-11-06 | Biovalve Technologies, Inc. | Electroactive pore |
US6743211B1 (en) * | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US20020156453A1 (en) * | 1999-10-14 | 2002-10-24 | Pettis Ronald J. | Method and device for reducing therapeutic dosage |
US20020095134A1 (en) * | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
AU2573801A (en) | 1999-11-02 | 2001-05-14 | University Of Hawaii | Method for fabricating arrays of micro-needles |
ES2248165T3 (en) * | 1999-11-15 | 2006-03-16 | Velcro Industries B.V. | SKIN FIXING ELEMENT. |
US6511463B1 (en) | 1999-11-18 | 2003-01-28 | Jds Uniphase Corporation | Methods of fabricating microneedle arrays using sacrificial molds |
US20030168396A1 (en) * | 1999-12-08 | 2003-09-11 | Jacobson James D. | Monolithic filter body and fabrication technique |
ATE523239T1 (en) * | 1999-12-08 | 2011-09-15 | Baxter Int | METHOD FOR PRODUCING MICROPOROUS FILTER MEMBRANES |
US6982058B2 (en) * | 1999-12-08 | 2006-01-03 | Baxter International, Inc. | Method for fabricating three dimensional structures |
US7427526B2 (en) * | 1999-12-20 | 2008-09-23 | The Penn State Research Foundation | Deposited thin films and their use in separation and sacrificial layer applications |
US6375627B1 (en) | 2000-03-02 | 2002-04-23 | Agilent Technologies, Inc. | Physiological fluid extraction with rapid analysis |
DE10010587A1 (en) | 2000-03-03 | 2001-09-06 | Roche Diagnostics Gmbh | System for the determination of analyte concentrations in body fluids |
DE10010694A1 (en) * | 2000-03-04 | 2001-09-06 | Roche Diagnostics Gmbh | Lancet including tipped needle with body surrounding tip |
AU2001245472A1 (en) * | 2000-03-09 | 2001-09-17 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier andproduction techniques for such systems |
EP1280617A4 (en) * | 2000-04-17 | 2005-08-03 | Penn State Res Found | Deposited thin films and their use in separation and sarcrificial layer applications |
US6595947B1 (en) * | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
US6503409B1 (en) * | 2000-05-25 | 2003-01-07 | Sandia Corporation | Lithographic fabrication of nanoapertures |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
AU6501201A (en) | 2000-06-01 | 2001-12-11 | Science Applic Int Corp | Systems and methods for monitoring health and delivering drugs transdermally |
US8366769B2 (en) | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
US7473244B2 (en) * | 2000-06-02 | 2009-01-06 | The University Of Utah Research Foundation | Active needle devices with integrated functionality |
US6540675B2 (en) * | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US20040175360A1 (en) * | 2000-06-29 | 2004-09-09 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
US20050008683A1 (en) * | 2000-06-29 | 2005-01-13 | Becton Dickinson And Company | Method for delivering interferons to the intradermal compartment |
US6771183B2 (en) * | 2000-07-03 | 2004-08-03 | Kodiak Technologies, Inc. | Advanced thermal container |
US7399599B2 (en) | 2000-07-10 | 2008-07-15 | Vertex Pharmaceuticals (San Diego) Llc | Ion channel assay methods |
US7615356B2 (en) * | 2000-07-10 | 2009-11-10 | Vertex Pharmaceuticals (San Diego) Llc | Ion channel assay methods |
US6533951B1 (en) * | 2000-07-27 | 2003-03-18 | Eastman Kodak Company | Method of manufacturing fluid pump |
US6562404B1 (en) * | 2000-08-25 | 2003-05-13 | The Regents Of The University Of California | Conformal chemically resistant coatings for microflow devices |
US6533949B1 (en) * | 2000-08-28 | 2003-03-18 | Nanopass Ltd. | Microneedle structure and production method therefor |
US6690959B2 (en) | 2000-09-01 | 2004-02-10 | Medtronic, Inc. | Skin-mounted electrodes with nano spikes |
DE10048375A1 (en) * | 2000-09-29 | 2002-05-08 | Michele Delsanter | Multifunctional and multiparametric biochip arrangement |
US6787339B1 (en) * | 2000-10-02 | 2004-09-07 | Motorola, Inc. | Microfluidic devices having embedded metal conductors and methods of fabricating said devices |
US6821281B2 (en) | 2000-10-16 | 2004-11-23 | The Procter & Gamble Company | Microstructures for treating and conditioning skin |
US7131987B2 (en) | 2000-10-16 | 2006-11-07 | Corium International, Inc. | Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation |
US7828827B2 (en) * | 2002-05-24 | 2010-11-09 | Corium International, Inc. | Method of exfoliation of skin using closely-packed microstructures |
DE10053974A1 (en) | 2000-10-31 | 2002-05-29 | Roche Diagnostics Gmbh | Blood collection system |
KR20020035694A (en) * | 2000-11-07 | 2002-05-15 | 양상식 | A micro syringe device and the manufacturing method |
US6537437B1 (en) | 2000-11-13 | 2003-03-25 | Sandia Corporation | Surface-micromachined microfluidic devices |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
WO2002064193A2 (en) * | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
AU2002231207A1 (en) * | 2000-12-21 | 2002-07-01 | Biovalve Technologies, Inc. | Microneedle array systems |
AU2002247008B2 (en) * | 2001-01-22 | 2006-02-09 | F. Hoffmann-La Roche Ag | Lancet device having capillary action |
US6756018B2 (en) * | 2001-02-12 | 2004-06-29 | Agilent Technologies, Inc. | Method and apparatus for selective execution of microfluidic circuits utilizing electrically addressable gas generators |
US6663820B2 (en) | 2001-03-14 | 2003-12-16 | The Procter & Gamble Company | Method of manufacturing microneedle structures using soft lithography and photolithography |
US7310543B2 (en) | 2001-03-26 | 2007-12-18 | Kumetrix, Inc. | Silicon microprobe with integrated biosensor |
BR0116972A (en) * | 2001-04-13 | 2004-12-21 | Becton Dickinson Co | Methods and devices for administering substances to the intradermal skin layer for systemic absorption |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
US20020177763A1 (en) * | 2001-05-22 | 2002-11-28 | Burns David W. | Integrated lancets and methods |
US20020188310A1 (en) * | 2001-06-08 | 2002-12-12 | Seward Kirk Partick | Microfabricated surgical device |
AU2002312380A1 (en) * | 2001-06-08 | 2002-12-23 | Becton, Dickinson And Company | Device for manipulating a needle or abrader array |
US20020188223A1 (en) | 2001-06-08 | 2002-12-12 | Edward Perez | Devices and methods for the expression of bodily fluids from an incision |
ATE335435T1 (en) | 2001-06-08 | 2006-09-15 | Hoffmann La Roche | BODY FLUID EXTRACTION DEVICE AND TEST MEDIA CASSETTE |
US7127284B2 (en) * | 2001-06-11 | 2006-10-24 | Mercator Medsystems, Inc. | Electroporation microneedle and methods for its use |
ATE497731T1 (en) * | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
US9226699B2 (en) * | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2003088851A1 (en) * | 2001-06-12 | 2003-10-30 | Pelikan Technologies, Inc. | Tissue penetration device |
CA2448905C (en) * | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
WO2002100253A2 (en) * | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Blood sampling device with diaphragm actuated lancet |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7316700B2 (en) * | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
ATE485766T1 (en) * | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | ELECTRICAL ACTUATING ELEMENT FOR A LANCET |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7025774B2 (en) * | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US6767341B2 (en) | 2001-06-13 | 2004-07-27 | Abbott Laboratories | Microneedles for minimally invasive drug delivery |
MXPA03011611A (en) * | 2001-06-29 | 2004-07-01 | Becton Dickinson Co | Intradermal delivery of vaccines and gene therapeutic agents via microcannula. |
US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
US20050010193A1 (en) * | 2002-05-06 | 2005-01-13 | Laurent Philippe E. | Novel methods for administration of drugs and devices useful thereof |
DE10134650B4 (en) * | 2001-07-20 | 2009-12-03 | Roche Diagnostics Gmbh | System for taking small amounts of body fluid |
US6825127B2 (en) | 2001-07-24 | 2004-11-30 | Zarlink Semiconductor Inc. | Micro-fluidic devices |
DE10142232B4 (en) * | 2001-08-29 | 2021-04-29 | Roche Diabetes Care Gmbh | Process for the production of an analytical aid with a lancet and test element |
EP1423049A2 (en) * | 2001-08-29 | 2004-06-02 | Roche Diagnostics GmbH | Wicking methods and structures for use in sampling bodily fluids |
US20040087992A1 (en) * | 2002-08-09 | 2004-05-06 | Vladimir Gartstein | Microstructures for delivering a composition cutaneously to skin using rotatable structures |
WO2003024507A2 (en) * | 2001-09-19 | 2003-03-27 | Biovalve Technologies, Inc. | Microneedles, microneedle arrays, and systems and methods relating to same |
WO2003024508A2 (en) * | 2001-09-21 | 2003-03-27 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
WO2003039369A1 (en) * | 2001-09-26 | 2003-05-15 | Roche Diagnostics Gmbh | Method and apparatus for sampling bodily fluid |
CA2500453A1 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
CA2500452A1 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Switchable microneedle arrays and systems and methods relating to same |
US6788966B2 (en) * | 2001-10-22 | 2004-09-07 | Transscan Medical Ltd. | Diagnosis probe |
US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
JP2005511248A (en) * | 2001-10-29 | 2005-04-28 | ベクトン・ディキンソン・アンド・カンパニー | Methods and devices for delivering substances |
US7209788B2 (en) * | 2001-10-29 | 2007-04-24 | Duke University | Closed loop brain machine interface |
US6989891B2 (en) * | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
US20030105409A1 (en) * | 2001-11-14 | 2003-06-05 | Donoghue John Philip | Neurological signal decoding |
US20040005258A1 (en) * | 2001-12-12 | 2004-01-08 | Fonash Stephen J. | Chemical reactor templates: sacrificial layer fabrication and template use |
US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
US7309620B2 (en) * | 2002-01-11 | 2007-12-18 | The Penn State Research Foundation | Use of sacrificial layers in the manufacture of high performance systems on tailored substrates |
US20040060902A1 (en) * | 2002-02-05 | 2004-04-01 | Evans John D. | Microprotrusion array and methods of making a microprotrusion |
US7004928B2 (en) * | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
JP3933058B2 (en) * | 2002-02-25 | 2007-06-20 | 日立化成工業株式会社 | Support unit for microfluidic system and method for manufacturing the same |
CA2419200C (en) * | 2002-03-05 | 2015-06-30 | Bayer Healthcare Llc | Fluid collection apparatus having an integrated lance and reaction area |
US6993392B2 (en) * | 2002-03-14 | 2006-01-31 | Duke University | Miniaturized high-density multichannel electrode array for long-term neuronal recordings |
US7371247B2 (en) * | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7141058B2 (en) * | 2002-04-19 | 2006-11-28 | Pelikan Technologies, Inc. | Method and apparatus for a body fluid sampling device using illumination |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) * | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) * | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) * | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7582099B2 (en) * | 2002-04-19 | 2009-09-01 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) * | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
AU2003231749A1 (en) * | 2002-04-19 | 2003-11-03 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) * | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7291117B2 (en) * | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) * | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7524293B2 (en) * | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7481776B2 (en) * | 2002-04-19 | 2009-01-27 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) * | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7563232B2 (en) * | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7374544B2 (en) * | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892185B2 (en) * | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7892183B2 (en) * | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) * | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) * | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7244265B2 (en) * | 2002-04-19 | 2007-07-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) * | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7410468B2 (en) * | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
WO2004054455A1 (en) * | 2002-12-13 | 2004-07-01 | Pelikan Technologies, Inc. | Method and apparatus for measuring analytes |
US20070142748A1 (en) * | 2002-04-19 | 2007-06-21 | Ajay Deshmukh | Tissue penetration device |
US8267870B2 (en) * | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9795334B2 (en) * | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7485128B2 (en) * | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9314194B2 (en) * | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP4764626B2 (en) | 2002-05-06 | 2011-09-07 | ベクトン・ディキンソン・アンド・カンパニー | Method and device for controlling the pharmacokinetics of a drug |
US20060264886A9 (en) * | 2002-05-06 | 2006-11-23 | Pettis Ronald J | Method for altering insulin pharmacokinetics |
US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US20030211619A1 (en) * | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
US7060192B2 (en) * | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
KR100479687B1 (en) * | 2002-05-30 | 2005-03-30 | 한국과학기술연구원 | Cantilever sensor and method for fabrication thereof |
US20030223906A1 (en) † | 2002-06-03 | 2003-12-04 | Mcallister Devin | Test strip container system |
WO2003101532A2 (en) * | 2002-06-04 | 2003-12-11 | Cyberkinetics, Inc. | Optically-connected implants and related systems and methods of use |
US7115881B2 (en) * | 2002-06-04 | 2006-10-03 | Mario Rabinowitz | Positioning and motion control by electrons, ions, and neutrals in electric fields |
US20040067481A1 (en) * | 2002-06-12 | 2004-04-08 | Leslie Leonard | Thermal sensor for fluid detection |
US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
JP2005537054A (en) * | 2002-08-30 | 2005-12-08 | ベクトン・ディキンソン・アンド・カンパニー | Methods for controlling the pharmacokinetics of immunomodulatory compounds |
AU2003275311A1 (en) * | 2002-09-16 | 2004-04-30 | Sung-Yun Kwon | Solid micro-perforators and methods of use |
IES20020794A2 (en) * | 2002-10-04 | 2003-02-19 | Minroc Techn Promotions Ltd | A down-the-hole hammer |
DE10247022B4 (en) * | 2002-10-09 | 2016-09-08 | Disetronic Licensing Ag | pinpoint |
US7212851B2 (en) | 2002-10-24 | 2007-05-01 | Brown University Research Foundation | Microstructured arrays for cortex interaction and related methods of manufacture and use |
US20050049522A1 (en) * | 2002-10-30 | 2005-03-03 | Allen John J | Method of lancing skin for the extraction of blood |
US7731900B2 (en) * | 2002-11-26 | 2010-06-08 | Roche Diagnostics Operations, Inc. | Body fluid testing device |
US20040178879A1 (en) * | 2002-12-13 | 2004-09-16 | Somenath Mitra | Micromachined heaters for microfluidic devices |
EP1578271B1 (en) | 2002-12-23 | 2011-05-25 | Roche Diagnostics GmbH | Body fluid testing device |
US7582258B2 (en) * | 2002-12-23 | 2009-09-01 | Roche Diagnostics Operations, Inc. | Body fluid testing device |
US7815579B2 (en) * | 2005-03-02 | 2010-10-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
WO2004071737A2 (en) * | 2003-02-04 | 2004-08-26 | Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University (Abr/Asu) | Using benzocyclobutene as a biocompatible material |
KR100562498B1 (en) * | 2003-02-12 | 2006-03-21 | 삼성전자주식회사 | Pad conditioner of cmp equipment |
US7578954B2 (en) * | 2003-02-24 | 2009-08-25 | Corium International, Inc. | Method for manufacturing microstructures having multiple microelements with through-holes |
US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
US20080149524A1 (en) * | 2003-03-27 | 2008-06-26 | Rademaker William B | Food containers including dental cleaning devices and other personal care items |
US20040193202A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Integrated lance and strip for analyte measurement |
US7473264B2 (en) * | 2003-03-28 | 2009-01-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
US20040193072A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
US20050070819A1 (en) * | 2003-03-31 | 2005-03-31 | Rosedale Medical, Inc. | Body fluid sampling constructions and techniques |
DE10315544B4 (en) * | 2003-04-04 | 2007-02-15 | Roche Diagnostics Gmbh | Method for producing a piercing and measuring device and device |
WO2004103147A2 (en) * | 2003-05-02 | 2004-12-02 | Pelikan Technologies, Inc. | Method and apparatus for a tissue penetrating device user interface |
JP2004343275A (en) * | 2003-05-14 | 2004-12-02 | Murata Mach Ltd | Image processing system and scanner |
US7374949B2 (en) * | 2003-05-29 | 2008-05-20 | Bayer Healthcare Llc | Diagnostic test strip for collecting and detecting an analyte in a fluid sample |
ATE476137T1 (en) | 2003-05-30 | 2010-08-15 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
WO2004107964A2 (en) * | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
US20040249302A1 (en) * | 2003-06-09 | 2004-12-09 | Cyberkinetics, Inc. | Methods and systems for processing of brain signals |
US20060241666A1 (en) * | 2003-06-11 | 2006-10-26 | Briggs Barry D | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US20050163711A1 (en) * | 2003-06-13 | 2005-07-28 | Becton, Dickinson And Company, Inc. | Intra-dermal delivery of biologically active agents |
WO2005020912A2 (en) * | 2003-08-25 | 2005-03-10 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
MXPA06002159A (en) * | 2003-08-26 | 2006-05-22 | Becton Dickinson Co | Methods for intradermal delivery of therapeutics agents. |
US8353861B2 (en) * | 2003-09-18 | 2013-01-15 | Texmac, Inc. | Applicator for applying functional substances into human skin |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) * | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
US20050143589A1 (en) * | 2003-11-09 | 2005-06-30 | Donoghue John P. | Calibration systems and methods for neural interface devices |
US20050113744A1 (en) * | 2003-11-21 | 2005-05-26 | Cyberkinetics, Inc. | Agent delivery systems and related methods under control of biological electrical signals |
US7751877B2 (en) * | 2003-11-25 | 2010-07-06 | Braingate Co., Llc | Neural interface system with embedded id |
EP1703925A1 (en) * | 2003-11-27 | 2006-09-27 | Commissariat A L'Energie Atomique | In vivo diagnostic and therapy micro-device |
US8017145B2 (en) * | 2003-12-22 | 2011-09-13 | Conopco, Inc. | Exfoliating personal care wipe article containing an array of projections |
US7647097B2 (en) * | 2003-12-29 | 2010-01-12 | Braingate Co., Llc | Transcutaneous implant |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) * | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
CN100571860C (en) * | 2004-02-18 | 2009-12-23 | 日立化成工业株式会社 | Micro fluid system support unit |
US20050187525A1 (en) * | 2004-02-19 | 2005-08-25 | Hilgers Michael E. | Devices and methods for extracting bodily fluid |
US20050256499A1 (en) * | 2004-03-03 | 2005-11-17 | Pettis Ronald J | Methods and devices for improving delivery of a substance to skin |
PL1725168T3 (en) * | 2004-03-06 | 2016-10-31 | Body fluid sampling device | |
US20050203366A1 (en) * | 2004-03-12 | 2005-09-15 | Donoghue John P. | Neurological event monitoring and therapy systems and related methods |
US20050203575A1 (en) * | 2004-03-15 | 2005-09-15 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Skin microactivation system and method |
AU2005228145B2 (en) * | 2004-03-24 | 2011-03-03 | Corium Pharma Solutions, Inc. | Transdermal delivery device |
US8024036B2 (en) | 2007-03-19 | 2011-09-20 | The Invention Science Fund I, Llc | Lumen-traveling biological interface device and method of use |
US20070010868A1 (en) * | 2004-04-19 | 2007-01-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Lumenally-active device |
US8512219B2 (en) * | 2004-04-19 | 2013-08-20 | The Invention Science Fund I, Llc | Bioelectromagnetic interface system |
US8353896B2 (en) * | 2004-04-19 | 2013-01-15 | The Invention Science Fund I, Llc | Controllable release nasal system |
US7850676B2 (en) * | 2004-04-19 | 2010-12-14 | The Invention Science Fund I, Llc | System with a reservoir for perfusion management |
US20070244520A1 (en) * | 2004-04-19 | 2007-10-18 | Searete Llc | Lumen-traveling biological interface device and method of use |
US8361013B2 (en) * | 2004-04-19 | 2013-01-29 | The Invention Science Fund I, Llc | Telescoping perfusion management system |
US7998060B2 (en) * | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling delivery device |
US7857767B2 (en) * | 2004-04-19 | 2010-12-28 | Invention Science Fund I, Llc | Lumen-traveling device |
US8337482B2 (en) * | 2004-04-19 | 2012-12-25 | The Invention Science Fund I, Llc | System for perfusion management |
US8092549B2 (en) * | 2004-09-24 | 2012-01-10 | The Invention Science Fund I, Llc | Ciliated stent-like-system |
US9011329B2 (en) * | 2004-04-19 | 2015-04-21 | Searete Llc | Lumenally-active device |
WO2005115360A2 (en) * | 2004-05-11 | 2005-12-08 | Becton, Dickinson And Company | Formulations of anti-pain agents and methods of using the same |
US7591806B2 (en) * | 2004-05-18 | 2009-09-22 | Bai Xu | High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances |
US8828203B2 (en) * | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US20050284757A1 (en) * | 2004-06-29 | 2005-12-29 | Allen John J | Analyte measuring system which prevents the reuse of a test strip |
US20050284773A1 (en) * | 2004-06-29 | 2005-12-29 | Allen John J | Method of preventing reuse in an analyte measuring system |
US20060030788A1 (en) * | 2004-08-04 | 2006-02-09 | Daniel Wong | Apparatus and method for extracting bodily fluid utilizing a flat lancet |
US20060058627A1 (en) * | 2004-08-13 | 2006-03-16 | Flaherty J C | Biological interface systems with wireless connection and related methods |
US8560041B2 (en) * | 2004-10-04 | 2013-10-15 | Braingate Co., Llc | Biological interface system |
DE102004048864A1 (en) * | 2004-10-07 | 2006-04-13 | Roche Diagnostics Gmbh | Analytical test element with wireless data transmission |
US7627938B2 (en) * | 2004-10-15 | 2009-12-08 | Board Of Regents, The Univeristy Of Texas System | Tapered hollow metallic microneedle array assembly and method of making and using the same |
CA2587216C (en) * | 2004-11-18 | 2014-11-18 | Nanopass Technologies Ltd. | System and method for delivering fluid into flexible biological barrier |
JP4687653B2 (en) * | 2004-11-30 | 2011-05-25 | 日立化成工業株式会社 | Analysis pretreatment parts |
JP2008522875A (en) | 2004-12-07 | 2008-07-03 | スリーエム イノベイティブ プロパティズ カンパニー | Microneedle molding method |
CN101664662A (en) * | 2004-12-09 | 2010-03-10 | 日立化成工业株式会社 | Support unit for micro fluid system and process for producing the same |
EP1671585A1 (en) * | 2004-12-17 | 2006-06-21 | F. Hoffmann-La Roche Ag | Method of manufacturing a lancet element |
US20060167382A1 (en) * | 2004-12-30 | 2006-07-27 | Ajay Deshmukh | Method and apparatus for storing an analyte sampling and measurement device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US20080214917A1 (en) * | 2004-12-30 | 2008-09-04 | Dirk Boecker | Method and apparatus for analyte measurement test time |
US7901368B2 (en) * | 2005-01-06 | 2011-03-08 | Braingate Co., Llc | Neurally controlled patient ambulation system |
US7991461B2 (en) * | 2005-01-06 | 2011-08-02 | Braingate Co., Llc | Patient training routine for biological interface system |
US8095209B2 (en) * | 2005-01-06 | 2012-01-10 | Braingate Co., Llc | Biological interface system with gated control signal |
US20060167564A1 (en) * | 2005-01-10 | 2006-07-27 | Flaherty J C | Limb and digit movement system |
WO2006076175A2 (en) * | 2005-01-10 | 2006-07-20 | Cyberkinetics Neurotechnology Systems, Inc. | Biological interface system with patient training apparatus |
US7881780B2 (en) * | 2005-01-18 | 2011-02-01 | Braingate Co., Llc | Biological interface system with thresholded configuration |
US20060184065A1 (en) * | 2005-02-10 | 2006-08-17 | Ajay Deshmukh | Method and apparatus for storing an analyte sampling and measurement device |
US7955271B2 (en) * | 2006-10-13 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
US7935063B2 (en) * | 2005-03-02 | 2011-05-03 | Roche Diagnostics Operations, Inc. | System and method for breaking a sterility seal to engage a lancet |
KR100787598B1 (en) * | 2005-05-17 | 2007-12-21 | 주식회사 크라또 | Probe unit and method of fabricating the probe unit |
US8048017B2 (en) * | 2005-05-18 | 2011-11-01 | Bai Xu | High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances |
US8043250B2 (en) * | 2005-05-18 | 2011-10-25 | Nanomed Devices, Inc. | High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances |
US20060281187A1 (en) * | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
WO2007002522A1 (en) | 2005-06-27 | 2007-01-04 | 3M Innovative Properties Company | Microneedle cartridge assembly and method of applying |
CN101687094B (en) * | 2005-09-06 | 2012-09-26 | 谢拉杰克特股份有限公司 | Solid solution perforator containing drug particle and/or drug-adsorbed particles |
CA2623589C (en) * | 2005-09-30 | 2014-07-22 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US20070191736A1 (en) * | 2005-10-04 | 2007-08-16 | Don Alden | Method for loading penetrating members in a collection device |
US20070276290A1 (en) * | 2005-10-04 | 2007-11-29 | Dirk Boecker | Tissue Penetrating Apparatus |
WO2007044599A2 (en) * | 2005-10-06 | 2007-04-19 | Hamilton Scott E | Pod connected data monitoring system |
US20070106143A1 (en) * | 2005-11-08 | 2007-05-10 | Flaherty J C | Electrode arrays and related methods |
US20080262416A1 (en) * | 2005-11-18 | 2008-10-23 | Duan Daniel C | Microneedle Arrays and Methods of Preparing Same |
US7651946B2 (en) * | 2005-12-12 | 2010-01-26 | University College Cork - National University Of Ireland, Cork | Wet etch processing |
US8308960B2 (en) | 2005-12-14 | 2012-11-13 | Silex Microsystems Ab | Methods for making micro needles and applications thereof |
ES2326286T3 (en) | 2005-12-19 | 2009-10-06 | F. Hoffmann-La Roche Ag | SANDWICH TYPE SENSOR TO DETERMINE THE CONCENTRATION OF AN ANALYTE. |
EP1797817A1 (en) | 2005-12-19 | 2007-06-20 | F.Hoffmann-La Roche Ag | Sandwich sensor for determining the concentration of an analyte |
US20070156126A1 (en) * | 2005-12-29 | 2007-07-05 | Flaherty J C | Medical device insertion system and related methods |
US20100023021A1 (en) * | 2005-12-27 | 2010-01-28 | Flaherty J Christopher | Biological Interface and Insertion |
US7699819B2 (en) | 2006-02-21 | 2010-04-20 | The Hong Kong University Of Science And Technology | Molecular sieve and zeolite microneedles and preparation thereof |
US9198563B2 (en) | 2006-04-12 | 2015-12-01 | The Invention Science Fund I, Llc | Temporal control of a lumen traveling device in a body tube tree |
EP3282250B1 (en) | 2006-08-08 | 2020-04-08 | Roche Diabetes Care GmbH | Electrochemical sensor for determining an analyte concentration |
US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
CN101516396B (en) | 2006-09-26 | 2013-10-09 | 传染性疾病研究院 | Vaccine composition containing synthetic adjuvant |
US8852124B2 (en) * | 2006-10-13 | 2014-10-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
US20080214987A1 (en) * | 2006-12-22 | 2008-09-04 | Nanomed Devices, Inc. | Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances |
US10525246B2 (en) | 2006-12-22 | 2020-01-07 | Nanomed Skincare, Inc. | Microdevice and method for transdermal delivery and sampling of active substances |
AU2008209537B2 (en) * | 2007-01-22 | 2013-01-31 | Corium Pharma Solutions, Inc. | Applicators for microneedle arrays |
US7799656B2 (en) * | 2007-03-15 | 2010-09-21 | Dalsa Semiconductor Inc. | Microchannels for BioMEMS devices |
ES2817249T3 (en) | 2007-04-16 | 2021-04-06 | Corium Inc | Microneedle matrices obtained by dissolution and casting containing an active principle |
EP1987761B1 (en) * | 2007-05-03 | 2019-10-23 | F. Hoffmann-La Roche AG | Tube-like sensor for proving an analyte |
WO2009029572A1 (en) * | 2007-08-24 | 2009-03-05 | Deka Products Limited Partnership | Microneedle systems and apparatus |
WO2009051901A2 (en) | 2007-08-30 | 2009-04-23 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
US8702932B2 (en) | 2007-08-30 | 2014-04-22 | Pepex Biomedical, Inc. | Electrochemical sensor and method for manufacturing |
WO2009048607A1 (en) * | 2007-10-10 | 2009-04-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
JP5178132B2 (en) * | 2007-10-11 | 2013-04-10 | キヤノン株式会社 | Image processing system and image processing method |
US20090209883A1 (en) * | 2008-01-17 | 2009-08-20 | Michael Higgins | Tissue penetrating apparatus |
US7766846B2 (en) | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
EP2265324B1 (en) * | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
CN102105108B (en) * | 2008-05-21 | 2013-12-04 | 谢拉杰克特股份有限公司 | Method of manufacturing solid solution peforator patches and uses thereof |
WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
US8886279B2 (en) * | 2008-06-03 | 2014-11-11 | University Of Utah Research Foundation | High aspect ratio microelectrode arrays enabled to have customizable lengths and methods of making the same |
JP5642066B2 (en) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid |
ES2907152T3 (en) | 2008-06-06 | 2022-04-22 | Intuity Medical Inc | Blood glucose meter and method of operation |
NL2001718C2 (en) * | 2008-06-24 | 2009-12-28 | Needle Holding B V U | Micro needle, micro needle array and manufacturing method therefor. |
US7927904B2 (en) | 2009-01-05 | 2011-04-19 | Dalsa Semiconductor Inc. | Method of making BIOMEMS devices |
US9375169B2 (en) * | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
FI20095433A0 (en) * | 2009-04-20 | 2009-04-20 | Valtion Teknillinen | micro-needle |
BRPI1015460A2 (en) | 2009-04-22 | 2020-08-18 | Mercator Medsystems, Inc. | guanetidine for use in the treatment of hypertension and hypertension treatment system |
ES2634667T3 (en) * | 2009-04-24 | 2017-09-28 | Corium International, Inc. | Methods for manufacturing microprojection assemblies |
US8353953B2 (en) * | 2009-05-13 | 2013-01-15 | Sorin Biomedica Cardio, S.R.L. | Device for the in situ delivery of heart valves |
RU2560182C2 (en) | 2009-06-05 | 2015-08-20 | Инфекшес Дизиз Рисерч Инститьют | Synthetic glucopyranosyllipid adjuvants |
WO2011011462A1 (en) | 2009-07-20 | 2011-01-27 | Optiscan Biomedical Corporation | Adjustable connector and dead space reduction |
EP2506921A4 (en) | 2009-11-30 | 2013-10-30 | Univ South Florida | Cubic silicon carbide implantable neural prosthetic |
EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
ES2719595T3 (en) | 2010-05-04 | 2019-07-11 | Corium Int Inc | Method and device for transdermal administration of parathyroid hormone using a microprojection matrix |
EP2584964B1 (en) | 2010-06-25 | 2021-08-04 | Intuity Medical, Inc. | Analyte monitoring devices |
WO2012075120A2 (en) | 2010-11-30 | 2012-06-07 | University Of South Florida | Graphene electrodes on a planar cubic silicon carbide (3c-sic) long term implantable neuronal prosthetic device |
WO2012098160A1 (en) | 2011-01-18 | 2012-07-26 | Imec | Disposable protection for micro-engineered devices |
EA027236B1 (en) | 2011-04-08 | 2017-07-31 | Иммьюн Дизайн Корп. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
EP4339613A2 (en) | 2011-08-03 | 2024-03-20 | Intuity Medical, Inc. | Body fluid sampling arrangement |
EP2570152B1 (en) | 2011-09-16 | 2018-08-22 | IMEC vzw | Structured probes for neural applications |
ES2549785T3 (en) * | 2011-09-23 | 2015-11-02 | F. Hoffmann-La Roche Ag | Engraving procedure by mask of a puncture element |
CA2887597C (en) | 2011-10-19 | 2018-01-09 | Mercator Medsystems, Inc. | Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation |
US9872982B2 (en) | 2012-01-10 | 2018-01-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Electroosmotic convection-enhanced delivery system |
SI2811981T1 (en) | 2012-02-07 | 2019-08-30 | Infectious Disease Research Institute | Improved adjuvant formulations comprising tlr4 agonists and methods of using the same |
ES2673556T3 (en) | 2012-05-16 | 2018-06-22 | Immune Design Corp. | Vaccines for HSV-2 |
EP2925229A4 (en) | 2012-12-03 | 2017-01-25 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
CA2896188C (en) | 2012-12-21 | 2021-02-23 | Corium International, Inc. | Microarray for delivery of therapeutic agent and methods of use |
AU2014249471B2 (en) | 2013-03-12 | 2019-01-24 | Corium Pharma Solutions, Inc. | Microprojection applicators |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
US10004434B1 (en) | 2013-03-15 | 2018-06-26 | Georgetown University | Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode |
SG11201506352SA (en) | 2013-03-15 | 2015-09-29 | Edwards Lifesciences Corp | Valved aortic conduits |
ES2939317T3 (en) | 2013-03-15 | 2023-04-20 | Corium Pharma Solutions Inc | Multi-impact micro-spray applicators |
MX2015012933A (en) | 2013-03-15 | 2016-09-19 | Corium Int Inc | Microarray for delivery of therapeutic agent and methods of use. |
JP2016512754A (en) | 2013-03-15 | 2016-05-09 | コリウム インターナショナル, インコーポレイテッド | Microarray, method of use and manufacturing for delivery of therapeutic agents |
CA2903763C (en) | 2013-03-15 | 2021-11-16 | Corium International, Inc. | Microarray with polymer-free microstructures, methods of making, and methods of use |
AU2014253791B2 (en) | 2013-04-18 | 2019-05-02 | Immune Design Corp. | GLA monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
JP2016522070A (en) | 2013-06-21 | 2016-07-28 | インテュイティ メディカル インコーポレイテッド | Analyte monitoring system using audible feedback |
US11185271B2 (en) * | 2013-09-13 | 2021-11-30 | University Of Utah Research Foundation | Methods of making micro-molded electrodes and arrays |
SG11201508895RA (en) | 2013-09-20 | 2015-11-27 | Edwards Lifesciences Corp | Heart valves with increased effective orifice area |
GB201318700D0 (en) | 2013-10-23 | 2013-12-04 | Univ Swansea | Manufacture of microneedles |
US20150122687A1 (en) | 2013-11-06 | 2015-05-07 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
SG11201605883UA (en) | 2014-01-21 | 2016-08-30 | Immune Design Corp | Compositions for use in the treatment of allergic conditions |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
CN107003264B (en) | 2014-06-04 | 2020-02-21 | 普佩克斯生物医药有限公司 | Electrochemical sensor and method of manufacturing an electrochemical sensor using advanced printing techniques |
CA2914094C (en) | 2014-06-20 | 2021-01-05 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10624843B2 (en) | 2014-09-04 | 2020-04-21 | Corium, Inc. | Microstructure array, methods of making, and methods of use |
WO2017004067A1 (en) | 2015-06-29 | 2017-01-05 | Corium International, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
WO2017023931A1 (en) | 2015-08-03 | 2017-02-09 | Georgetown University | Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
MX2018013640A (en) | 2016-05-16 | 2019-08-01 | Infectious Disease Res Inst | Pegylated liposomes and methods of use. |
DK3458475T3 (en) | 2016-05-16 | 2022-09-12 | Access To Advanced Health Inst | FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE |
MX2021010105A (en) | 2016-06-01 | 2022-06-16 | Infectious Disease Res Inst | Nanoalum particles containing a sizing agent. |
CN110494126A (en) | 2016-12-22 | 2019-11-22 | 俄亥俄州国家创新基金会 | Run through micro-structure for the cargo delivering based on nanochannel |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
CA3060663A1 (en) | 2017-04-28 | 2018-11-01 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
CA3066915A1 (en) | 2017-06-11 | 2018-12-20 | Molecular Express, Inc. | Methods and compositions for substance use disorder vaccine formulations and uses thereof |
CN110831547B (en) | 2017-06-21 | 2022-07-15 | 爱德华兹生命科学公司 | Double-wire limited expansion heart valve |
EP4076284A1 (en) | 2019-12-16 | 2022-10-26 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
EP4048308A1 (en) | 2020-12-23 | 2022-08-31 | Infectious Disease Research Institute | Solanesol vaccine adjuvants and methods of preparing same |
US11476897B2 (en) | 2021-01-28 | 2022-10-18 | Nucurrent, Inc. | Wireless power transmitter for high fidelity communications at high power transfer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874499A (en) * | 1988-05-23 | 1989-10-17 | Massachusetts Institute Of Technology | Electrochemical microsensors and method of making such sensors |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221567A (en) * | 1977-12-23 | 1980-09-09 | Intermountain Health Care | Sampling and determination of diffusible chemical substances |
US4461304A (en) * | 1979-11-05 | 1984-07-24 | Massachusetts Institute Of Technology | Microelectrode and assembly for parallel recording of neurol groups |
NL8001420A (en) * | 1980-03-10 | 1981-10-01 | Cordis Europ | ELECTRODE COMPOSITIVE COMPOSITE, FOR AN ELECTROCHEMICAL MEASUREMENT, IN PARTICULAR AN ISFET-CONSTRUCTED COMPOSITION, AND METHOD FOR MANUFACTURING THE ASSEMBLY. |
GB2096825A (en) * | 1981-04-09 | 1982-10-20 | Sibbald Alastair | Chemical sensitive semiconductor field effect transducer |
US4969468A (en) * | 1986-06-17 | 1990-11-13 | Alfred E. Mann Foundation For Scientific Research | Electrode array for use in connection with a living body and method of manufacture |
US4902278A (en) * | 1987-02-18 | 1990-02-20 | Ivac Corporation | Fluid delivery micropump |
FR2648353B1 (en) * | 1989-06-16 | 1992-03-27 | Europhor Sa | MICRODIALYSIS PROBE |
US5285131A (en) * | 1990-12-03 | 1994-02-08 | University Of California - Berkeley | Vacuum-sealed silicon incandescent light |
US5130276A (en) * | 1991-05-16 | 1992-07-14 | Motorola Inc. | Method of fabricating surface micromachined structures |
US5498392A (en) * | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
US5304487A (en) * | 1992-05-01 | 1994-04-19 | Trustees Of The University Of Pennsylvania | Fluid handling in mesoscale analytical devices |
US5486335A (en) * | 1992-05-01 | 1996-01-23 | Trustees Of The University Of Pennsylvania | Analysis based on flow restriction |
US5296375A (en) * | 1992-05-01 | 1994-03-22 | Trustees Of The University Of Pennsylvania | Mesoscale sperm handling devices |
-
1994
- 1994-06-06 US US08/254,328 patent/US5591139A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 WO PCT/US1995/007916 patent/WO1995033504A1/en active Application Filing
- 1995-06-06 AU AU29072/95A patent/AU2907295A/en not_active Abandoned
-
1997
- 1997-01-07 US US08/779,504 patent/US5855801A/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874499A (en) * | 1988-05-23 | 1989-10-17 | Massachusetts Institute Of Technology | Electrochemical microsensors and method of making such sensors |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1008315C2 (en) * | 1998-02-16 | 1999-08-25 | Stichting Fund Ond Material | Microdialysis probe integrated with Si chip. |
WO1999041606A1 (en) * | 1998-02-16 | 1999-08-19 | Stichting Voor Fundamenteel Onderzoek Der Materie | Microdialysis-probe integrated with a si-chip |
US8298487B2 (en) | 2000-12-12 | 2012-10-30 | Bayer Healthcare Llc | Method of forming an electrochemical sensor |
WO2002049507A1 (en) | 2000-12-19 | 2002-06-27 | Inverness Medical Limited | Analyte measurement |
EP1359837B1 (en) * | 2000-12-19 | 2013-05-22 | Lifescan Scotland Ltd | Analyte measurement |
EP1267159A2 (en) * | 2001-06-11 | 2002-12-18 | Bayer Corporation | Electrochemical sensor and method of making |
US7122102B2 (en) | 2001-06-11 | 2006-10-17 | Bayer Healthcare Llc | Electrochemical sensor |
EP1267159A3 (en) * | 2001-06-11 | 2004-06-16 | Bayer Corporation | Electrochemical sensor and method of making |
EP1911394A1 (en) * | 2006-10-14 | 2008-04-16 | Roche Diagnostics GmbH | Lancet with capillar channel |
WO2008043498A1 (en) * | 2006-10-14 | 2008-04-17 | Roche Diagnostics Gmbh | Lancet with capillary channel |
EP1967581A1 (en) * | 2007-03-08 | 2008-09-10 | Interuniversitair Microelektronica Centrum | CMOS compatible microneedle structures |
US8452369B2 (en) * | 2007-03-08 | 2013-05-28 | Imec | CMOS compatible microneedle structures |
US9551698B2 (en) | 2009-12-30 | 2017-01-24 | Imec | Microneedle |
EP2708889A1 (en) * | 2012-09-12 | 2014-03-19 | Universität Leipzig | Method and device for obtaining a tissue sample and for characterizing the tissue sample by determining at least one electrical property |
Also Published As
Publication number | Publication date |
---|---|
US5591139A (en) | 1997-01-07 |
AU2907295A (en) | 1996-01-04 |
US5855801A (en) | 1999-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5855801A (en) | IC-processed microneedles | |
Lin et al. | Silicon-processed microneedles | |
Gardeniers et al. | Silicon micromachined hollow microneedles for transdermal liquid transport | |
EP1695734B1 (en) | Microneedles for minimally invasive drug delivery or for diagnostic sampling | |
US6558361B1 (en) | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems | |
Aggarwal et al. | Geometrical effects in mechanical characterizing of microneedle for biomedical applications | |
US7753888B2 (en) | Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles | |
US7285113B2 (en) | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems | |
Stoeber et al. | Arrays of hollow out-of-plane microneedles for drug delivery | |
US7344499B1 (en) | Microneedle device for extraction and sensing of bodily fluids | |
Polla et al. | Ferroelectric thin films in micro-electromechanical systems applications | |
Seidl et al. | In-plane silicon probes for simultaneous neural recording and drug delivery | |
US6187210B1 (en) | Epidermal abrasion device with isotropically etched tips, and method of fabricating such a device | |
EP1967581B1 (en) | CMOS compatible method for manufacturing microneedle structures | |
US20070007240A1 (en) | Wafer-level, polymer-based encapsulation for microstructure devices | |
EP0789146A1 (en) | Microvalve and method of manufacturing the same, micropump using the microvalve and method of manufacturing the same, and apparatus using the micropump | |
KR100384283B1 (en) | Single crystal silicon micro needle and method for manufacturing the same | |
EP1276426A2 (en) | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems | |
WO2007122552A2 (en) | Device for the controlled release of a substance and method of releasing a substance | |
Takei et al. | Integration of out-of-plane silicon dioxide microtubes, silicon microprobes and on-chip NMOSFETs by selective vapor–liquid–solid growth | |
Sparks et al. | Micromachined needles and lancets with design adjustable bevel angles | |
Mukerjee et al. | Microneedle array with integrated microchannels for transdermal sample extraction and in situ analysis | |
Berry et al. | Dermal ISF collection using a Si microneedle array | |
JP2002369816A (en) | Hollow needle, inspection chip using the same and blood analyzer | |
Zhang et al. | Micromachined needles for microbiological sample and drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |